UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM

10-Q

(MARK ONE)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~October~~

July 2 ~~2021~~

, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

Commission file number

0-26946

INTEVAC, INC.

(Exact name of registrant as specified in its charter)


Delaware		94-3125814
(State or other jurisdiction of incorporation or organization)		(IRS Employer Identification No.)

3560 Bassett Street

Santa Clara, California 95054

(Address of principal executive office, including Zip Code)

Registrant’s telephone number, including area code: (408)

986-9888

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock ($0.001 par value)	IVAC	The Nasdaq Stock Market LLC (Nasdaq) Global Select

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒

Yes

☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in

Rule 12b-2

of the Exchange Act:


Large accelerated filer	☐	Accelerated filer	☒

Non-accelerated filer	☐	Smaller reporting company	☒


		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in

Rule 12b-2

of the Act). ☐ Yes ☒ No

On ~~November~~August 4, 2 ~~2021,~~

~~24,590,904~~022, 25,384,488 sha

~~shares~~

res of the ~~Registrant’s~~registrant’s Common Stock, $0.001 par value, were outstanding.

Table of Contents

INTEVAC, INC.

INDEX


No.		Page
PART I. FINANCIAL INFORMATION
Item 1.	~~PART I. FINANCIAL INFORMATION~~Financial Statements (unaudited)

~~Item 1.~~	~~Financial Statements (unaudited)~~
	Condensed Consolidated Balance Sheets		3
	Condensed Consolidated Statements of Operations		4
	Condensed Consolidated Statements of Comprehensive ~~Income (Loss)~~Loss		5
	Condensed Consolidated Statements of Cash Flows		6
	Notes to Condensed Consolidated Financial Statements		7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		2223
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		30
Item 4.	Controls and Procedures		30

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings		31
Item 1A.	Risk Factors		31
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		37
Item 3.	Defaults ~~upon~~Upon Senior Securities		37
Item 4.	Mine Safety Disclosures		37
Item 5.	Other Information		37
Item 6.	Exhibits		37
SIGNATURES			38
~~Item 6.~~	~~Exhibits~~		38

~~SIGNATURES~~			39

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

INTEVAC, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

October 2,

2021

January 2,

2021



(Unaudited)


(In thousands, except par value)

ASSETS

Current assets:

Cash and cash equivalents
   $ 33,696 $ 29,341
Short-term investments
   11,137 14,839
Trade and other accounts receivable, net of allowances of $0 at both October 2, 2021 and at January 2, 2021
   13,470 28,646
Inventories
   22,453 21,689
Prepaid expenses and other current assets
   1,981 1,893


Total current assets
   82,737 96,408
Long-term investments
   5,825 5,388
Restricted cash
   786 787
Property, plant and equipment, net
   9,209 11,004
Operating lease
right-of-use-assets
   6,382 8,165
Deferred income taxes and other long-term assets
   5,554 5,486


Total assets
   $ 110,493 $ 127,238


LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Current operating lease liabilities
   $ 3,047 $ 2,853
Accounts payable
   4,659 4,259
Accrued payroll and related liabilities
   5,657 7,679
Other accrued liabilities
   2,649 3,631


Total current liabilities
   16,012 18,422
Noncurrent liabilities:

Noncurrent operating lease liabilities
   4,476 6,803
Other long-term liabilities
   450 457


Total noncurrent liabilities
   4,926 7,260
Stockholders’ equity:

Common stock, $0.001 par value
   25 24
Additional
paid-in
capital
   198,117 193,173
Treasury stock, 5,087 shares at both October 2, 2021 and at January 2, 2021
   (29,551 ) (29,551 )
Accumulated other comprehensive income
   557 640
Accumulated deficit
   (79,593 ) (62,730 )


Total stockholders’ equity
   89,555 101,556


Total liabilities and stockholders’ equity
   $ 110,493 $ 127,238


	July 2, 2022			January 1, 2022

	(Unaudited)
	(In thousands, except par value)
ASSETS
Current assets:
Cash and cash equivalents	$	53,669		$	102,728
Short-term investments		31,168			10,221
Trade and other accounts receivable, net of allowances of $0 at both July 2, 2022 and January 1, 2022		30,321			14,261
Inventories		11,771			5,791
Prepaid expenses and other current assets		1,532			1,827

Total current assets		128,461			134,828
Long-term investments		24,565			7,427
Restricted cash		786			786
Property, plant and equipment, net		3,311			4,759
Operating lease right-of-use-assets		3,510			4,520
Deferred income taxes and other long-term assets		5,018			5,449

Total assets	$	165,651		$	157,769

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Current operating lease liabilities	$	3,199		$	3,119
Accounts payable		3,609			5,320
Accrued payroll and related liabilities		3,542			5,505
Other accrued liabilities		3,042			3,665
Customer advances		24,760			2,107

Total current liabilities		38,152			19,716

Noncurrent liabilities:
Noncurrent operating lease liabilities		2,102			3,675
Other long-term liabilities		237			363

Total noncurrent liabilities		2,339			4,038
Stockholders’ equity:
Common stock, $0.001 par value		25			25
Additional paid-in capital		201,478			199,073
Treasury stock, 5,087 shares at both July 2, 2022 and at January 1, 2022		(29,551	)		(29,551	)
Accumulated other comprehensive income (loss)		(9	)		578
Accumulated deficit		(46,783	)		(36,110	)

Total stockholders’ equity		125,160			134,015

Total liabilities and stockholders’ equity	$	165,651		$	157,769

Note: Amounts as of January ~~2, 2021~~1, 2022 are derived from the January ~~2, 2021~~1, 2022 audited consolidated financial statements.

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

Three Months Ended

Nine Months Ended



October 2,

2021

September 26,

2020

October 2,

2021

September 26,

2020



(Unaudited)


(In thousands, except per share amounts)

Net revenues:

Systems and components
   $ 11,700 $ 15,027 $ 35,410 $ 51,589
Technology development
   3,093 6,538 9,437 17,659


Total net revenues
   14,793 21,565 44,847 69,248
Cost of net revenues:

Systems and components
   7,120 8,389 25,708 29,969
Technology development
   2,146 3,876 7,450 10,403


Total cost of net revenues
   9,266 12,265 33,158 40,372


Gross profit
   5,527 9,300 11,689 28,876
Operating expenses:

Research and development
   3,743 3,603 11,262 10,594
Selling, general and administrative
   5,752 5,845 17,208 17,426


Total operating expenses
   9,495 9,448 28,470 28,020


Income (loss) from operations
   (3,968 ) (148 ) (16,781 ) 856
Interest income and other income (expense), net
   25 8 75 212


Income (loss) before provision for income taxes
   (3,943 ) (140 ) (16,706 ) 1,068
Provision for income taxes
   290 217 157 1,125


Net loss
   $ (4,233 ) $ (357 ) $ (16,863 ) $ (57 )


Net loss per share:

Basic and Diluted
   $ (0.17 ) $ (0.02 ) $ (0.69 ) $ (0.00 )

Weighted average common shares outstanding:

Basic and Diluted
   24,522 23,771 24,265 23,605


	Three Months Ended						Six Months Ended
	July 2, 2022			July 3, 2021			July 2, 2022			July 3, 2021

	(Unaudited)
	(In thousands, except per share amounts)
Net revenues	$	9,307		$	5,369		$	13,752		$	14,607
Cost of net revenues		4,820			4,363			8,543			11,467

Gross profit		4,487			1,006			5,209			3,140
Operating expenses:
Research and development		2,868			3,118			7,028			6,483
Selling, general and administrative		4,016			4,197			8,265			8,531

Total operating expenses		6,884			7,315			15,293			15,014

Loss from operations		(2,397	)		(6,309	)		(10,084	)		(11,874	)
Interest income and other income (expense), net		317			20			310			50

Loss from continuing operations before provision for (benefit from) income taxes		(2,080	)		(6,289	)		(9,774	)		(11,824	)
Provision for (benefit from) income taxes		500			(165	)		526			(132	)

Net loss from continuing operations, net of taxes		(2,580	)		(6,124	)		(10,300	)		(11,692	)

Net loss from discontinued operations, net of taxes		(238	)		(2	)		(373	)		(938	)

Net loss	$	(2,818	)	$	(6,126	)	$	(10,673	)	$	(12,630	)

Net loss per share:
Basic and diluted – continuing operations	$	(0.10	)	$	(0.25	)	$	(0.41	)	$	(0.48	)
Basic and diluted – discontinued operations	$	(0.01	)	$	(0.00	)	$	(0.01	)	$	(0.04	)
Basic and diluted – net loss	$	(0.11	)	$	(0.25	)	$	(0.43	)	$	(0.52	)
Weighted average common shares outstanding:
Basic and diluted		25,141			24,241			24,970			24,137

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE ~~INCOME (LOSS)~~

LOSS


	Three Months Ended						Nine Months Ended
													Three Months Ended						Six Months Ended
	October 2, 2021			September 26, 2020			October 2, 2021			September 26, 2020			July 2, 2022			July 3, 2021			July 2, 2022			July 3, 2021

	(Unaudited) (In thousands)												(Unaudited)
													(In thousands)
Net loss	$	(4,233	)	$	(357	)	$	(16,863	)	$	(57	)	$	(2,818	)	$	(6,126	)	$	(10,673	)	$	(12,630	)

Other comprehensive income (loss), before tax
Change in unrealized net gain on available-for-sale investments		(7	)		(24	)		(36	)		29
Other comprehensive income (loss), before tax:
Change in unrealized net gain (loss) on available-for-sale investments														(161	)		(9	)		(335	)		(29	)
Foreign currency translation gains (losses)		(7	)		124			(47	)		49			(219	)		28			(252	)		(40	)

Other comprehensive income (loss), before tax		(14	)		100			(83	)		78			(380	)		19			(587	)		(69	)
Income tax (expense) benefit related to items in other comprehensive income (loss)		0			0			0			0
Income taxes related to items in other comprehensive income (loss)														0—			0—			0 —			0 —

Other comprehensive income (loss), net of tax		(14	)		100			(83	)		78			(380	)		19			(587	)		(69	)

Comprehensive income (loss)	$	(4,247	)	$	(257	)	$	(16,946	)	$	21
Comprehensive loss													$	(3,198	)	$	(6,107	)	$	(11,260	)	$	(12,699	)

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

INTEVAC, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS


	Nine months ended						Six months ended
	October 2, 2021			September 26, 2020			July 2, 2022			July 3, 2021
						��
	(Unaudited) (In thousands)						(Unaudited)
							(In thousands)
Operating activities
Net loss	$	(16,863	)	$	(57	)	$	(10,673	)	$	(12,630	)
Adjustments to reconcile net loss to net cash and cash equivalents provided by (used in) operating activities:
Depreciation and amortization		2,568			2,645			776			1,686
Net amortization (accretion) of investment premiums and discounts		88			(9	)		(20	)		62
Equity-based compensation		2,872			2,186			489			1,987
Straight-line rent adjustment and amortization of lease incentives		(350	)		(224	)		(483	)		(231	)
Deferred income taxes		(36	)		516			345			(202	)
Loss on disposal of equipment								1,453			0—
Changes in operating assets and liabilities		11,681			2,714			(3,322	)		12,692

Total adjustments		16,823			7,828			(762	)		15,994

Net cash and cash equivalents provided by (used in) operating activities		(40	)		7,771			(11,435	)		3,364
Investing activities
Purchases of investments		(13,214	)		(17,071	)		(45,663	)		(10,163	)
Proceeds from sales and maturities of investments		16,355			17,950			7,263			9,815
Purchases of leasehold improvements and equipment		(773	)		(2,329	)		(888	)		(365	)

Net cash and cash equivalents provided by (used in) investing activities		2,368			(1,450	)
Net cash and cash equivalents used in investing activities								(39,288	)		(713	)
Financing activities
Net proceeds from issuance of common stock		2,618			1,865			2,211			1,436
Common stock repurchases		0			(393	)
Taxes paid related to net share settlement		(545	)		(364	)		(295	)		(532	)

Net cash and cash equivalents provided by financing activities		2,073			1,108			1,916			904
Effect of exchange rate changes on cash		(47	)		49
Effect of exchange rate changes on cash and cash equivalents								(252	)		(40	)

Net increase in cash, cash equivalents and restricted cash		4,354			7,478
Net increase (decrease) in cash, cash equivalents and restricted cash								(49,059	)		3,515
Cash, cash equivalents and restricted cash at beginning of period		30,128			20,554			103,514			30,128

Cash, cash equivalents and restricted cash at end of period	$	34,482		$	28,032		$	54,455		$	33,643


Non-cash investing and financing activity
Additions to right-of-use-assets obtained from new operating lease liabilities	$	0		$	128		$	94		$	—

See accompanying notes to the condensed consolidated financial statements.

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1.	Description of Business and Basis of Presentation

Description of Business

Intevac, Inc. (together with its subsidiaries, ~~“Intevac,”~~“Intevac”, the “Company” or “we”) is a ~~provider~~leader in the design and development of ~~vacuum deposition equipment~~high-productivity, thin-film processing systems. Intevac’s production-proven platforms are designed for ~~a wide variety of thin-film applications, and a leading provider of digital night-vision technologies and products to the defense industry. The Company leverages its core capabilities in~~ high-volume manufacturing of ~~small~~ substrates ~~to provide process manufacturing equipment solutions to~~with precise thin-film properties, such as for the hard disk drive (“HDD”), and display cover panel (“DCP”), photovoltaic (“PV”) solar cell and advanced semiconductor packaging (“ASP”) industries. Intevac also provides sensors, cameras and systems for government applications such as night vision. Intevac’s customers include manufacturers of hard disk media, DCPs and solar cells as well as the U.S. government and its agencies, allies and contractors. Intevac reports two segments: Thin-film Equipment (“TFE”) and Photonics. markets.

Principles of Consolidation and Basis of Presentation

The condensed consolidated financial statements include the accounts of Intevac, Inc. and its subsidiaries after elimination of inter-company balances and transactions.

In the opinion of management, the unaudited interim condensed consolidated financial statements of Intevac included herein have been prepared on a basis consistent with the January ~~2, 2021~~1, 2022 audited consolidated financial statements and include all material adjustments, consisting of normal recurring adjustments, necessary to fairly present the information set forth therein. ~~Intevac’s results of operations for the three and nine months ended October 2, 2021 are not necessarily indicative of future operating results.~~

The preparation of ~~consolidated~~ financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make ~~judgments,~~ estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

~~COVID-19~~

~~Update~~Reportable Segment

During fiscal 2021, we sold the business of one of our reporting segments, Photonics. Therefore, we have one reportable segment remaining. See Note 2 for additional disclosure related to discontinued operations.

The ~~COVID-19~~

~~outbreak, which was declared a global pandemic by~~remaining segment, Thin Film Equipment (“TFE”), designs, develops and markets vacuum process equipment solutions for high-volume manufacturing of small substrates with precise thin-film properties, such as for the ~~World Health Organization in March 2020, has impacted all countries in which we operate. The impact of~~

~~COVID-19,~~

~~including changes in consumer behavior, pandemic fears,~~HDD, and ~~market downturns~~DCP markets, as well as ~~restrictions on~~other adjacent thin-film markets. The TFE segment also previously designed, developed and marketed manufacturing equipment for the photovoltaic (“PV”) solar cell and advanced semiconductor packaging industries.

In March 2022, the Company’s management approved a restructuring plan to realign the Company’s operational focus, scale the business and ~~individual activities has created significant volatility~~improve costs. The restructuring program includes (i) reducing the Company’s headcount and (ii) eliminating several research and development (“R&D”) programs and product offerings. As part of this realignment effort, the Company will no longer be pursuing several DCP projects, including the coating of the backside covers of smartphones, PV solar ion implantation (also known as ENERGi

), and advanced semiconductor packaging.

Reclassification of Prior Periods

On December 30, 2021, the Company completed the sale of its Photonics business to EOTECH, LLC, a Michigan limited liability company (“EOTECH” or the “Buyer”). Due to the sale of the Photonics business during the fourth quarter of 2021, we have classified the results of the Photonics business as discontinued operations in our condensed consolidated statements of operations for all periods presented. See Note 2 for additional disclosure related to discontinued operations. All amounts included in the ~~global economy and led~~Notes to ~~reduced economic activity. There have been extraordinary actions taken by federal, state, and local public health and governmental authorities~~Condensed Consolidated Financial Statements relate to ~~contain~~continuing operations unless otherwise noted.

2.	Divestiture and Discontinued Operations

Sale of Photonics

On December 30, 2021, the ~~spread of~~

~~COVID-19~~

and although many restrictions that were in place have eased in many localities, some areas that had previously eased restrictions have reverted to more stringent limitations. There remains significant uncertainty concerningCompany entered into an asset purchase agreement (the “Purchase Agreement”) with EOTECH, governing the ~~magnitude~~sale of the ~~impact~~Company’s Photonics business to EOTECH in exchange for (i) $70.0 million in cash consideration (as may be increased or decreased by certain closing net working capital adjustments), (ii) up to $30.0 million in earnout payments and (iii) the ~~duration of the~~

~~COVID-19~~

pandemic. Given that, we are unable to predict the ultimate impact it may have on our business, future operations, financial position or cash flows. The extent that our operations will continue to be impacted by the

~~COVID-19~~

pandemic will depend on future developments, including any new potential waves of the virus, new strains of the virus, and the success of vaccination programs, all of which are highly uncertain and cannot be accurately predicted. However, we are monitoring the progression of the pandemic and its potential effect on our financial position, results of operations, and cash flows.

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

assumption by EOTECH of certain liabilities of the Photonics business as specified in the Purchase Agreement. The transaction closed on December 30, 2021. Under the Purchase Agreement, EOTECH has also agreed to pay to the Company, if earned, earnout payments of up to an aggregate of $30.0 million based on achievement of fiscal year 2023, 2024 and 2025 Photonics segment revenue targets for the Integrated Visual Augmentation System (“IVAS”) program as specified in the Purchase Agreement. At any time prior to December 31, 2024, EOTECH may elect to pay to the Company $14.0 million, which would terminate EOTECH’s obligations with respect to any remaining earnout payments. The cash proceeds do not include any estimated future payments from the revenue earnout as the Company has elected to record the proceeds when the consideration is deemed realizable. The Company believes this disposition will allow it to benefit from a streamlined business model, simplified operating structure, and enhanced management focus.

In connection with the Photonics sale, the Company and EOTECH have entered into a Transition Service Agreement (“TSA”) and a Lease Assignment Agreement. The TSA outlines the information technology, people, and facility support the parties will provide to each other for a period anticipated to be up to six months after the closing of the sale. The Lease Assignment Agreement assigns the lease obligation for two buildings in the Company’s California campus to EOTECH. As part of the assignment, the Company has agreed to subsidize a portion of EOTECH’s lease payments through the remainder of the lease term which expires in March 2024.

TSA fees earned since the divestiture were $408,000 for the three months ended July 2, 2022 and $1.2 million for the six months ended July 2, 2022. The agreed-upon charges for such services are generally intended to allow the service provider to recover all costs and expenses of providing such services. The TSA fees were included in selling, general and administrative expenses and cost of sales, respectively, in the Company’s condensed consolidated statement of operations. Additionally, during the three and six months ended July 2, 2022, the Company sold inventory in the amount of $32,000 and $148,000, respectively to EOTECH. As of July 2, 2022, accounts receivable from EOTECH of $354,000 were included in trade and other accounts receivable in the Company’s condensed consolidated balance sheets.

Based on its magnitude and because the Company exited certain markets, the sale of the Photonics segment represents a significant strategic shift that has a material effect on the Company’s operations and financial results, and the Company has separately reported the results of its Photonics segment as discontinued operations in the condensed consolidated statements of operations for the three and six months ended July 2, 2022 and July 3, 2021.

The operating results of the discontinued operations only reflect revenues and expenses that are directly attributable to the Photonics segment that have been eliminated from continuing operations. Previously reported expenses for the Photonics segment have been recast to exclude certain allocated expenses that are not directly attributable to the Photonics segment. The key components from discontinued operations related to the Photonics segment are as follows:


	Three Months Ended						Six Months Ended
	July 2, 2022			July 3, 2021			July 2, 2022			July 3, 2021

	(In thousands)
Net revenues:
Systems and components	$	—		$	5,282		$	—		$	9,103
Technology development		—			3,162			—			6,344

Total net revenues		—			8,444			—			15,447
Cost of net revenues:
Systems and components		—			4,261			—			7,121
Technology development		—			2,081			—			5,304

Total cost of net revenues		—			6,342			—			12,425

Gross profit		—			2,102			—			3,022
Operating expenses:
Research and development		—			776			—			1,036
Selling, general and administrative		238			1,328			373			2,924

Total operating expenses		238			2,104			373			3,960

Operating loss – discontinued operations		(238	)		(2	)		(373	)		(938	)
Other income (expense) – discontinued operations		0—			0—			0—			0—

Loss from discontinued operations before provision for income taxes		(238	)		(2	)		(373	)		(938	)
Provision for income taxes		—			—			—			—

Net loss from discontinued operations, net of taxes	$	(238	)	$	(2	)	$	(373	)	$	(938	)

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

The cash flows related to discontinued operations have not been segregated and are included in the condensed consolidated statements of cash flows. The following table presents cash flow and

non-cash

information related to discontinued operations for the three and six months ended July 2, 2022 and July 3, 2021:


	Three Months Ended				Six Months Ended

	July 2, 2022		July 3, 2021		July 2, 2022			July 3, 2021
1	1
	(In thousands)
Depreciation and amortization	$	—	$	375	$	—		$	661
Equity-based compensation	$	39	$	247	$	(291	)	$	518
Purchase of leasehold improvements and equipment	$	—	$	76	$	—		$	149

2.3.

Revenue

The following tables represent a disaggregation of revenue from contracts with customers for the three and ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 and ~~September 26, 2020 along with the reportable segment for each category.~~July 3, 2021.

Major Products and Service Lines


TFE	Three Months Ended October 2, 2021										Three Months Ended September 26, 2020
																	Three Months Ended July 2, 2022								Three Months Ended July 3, 2021

	(In thousands)																(In thousands)
	HDD		DCP		PV		ASP		Total		HDD		PV		Total		HDD		DCP		PV		Total		HDD		DCP		PV		Total

Systems, upgrades and spare parts	$	6,495	$	0	$	61	$	0	$	6,556	$	7,601	$	131	$	7,732	$	7,756	$	1	$	82	$	7,839	$	3,955	$	3	$	47	$	4,005
Field service		1,424		0		18		0		1,442		1,635		0		1,635		1,421		43		4		1,468		1,364		—		—		1,364

Total TFE net revenues	$	7,919	$	0	$	79	$	0	$	7,998	$	9,236	$	131	$	9,367
Total net revenues																	$	9,177	$	44	$	86	$	9,307	$	5,319	$	3	$	47	$	5,369

Nine Months Ended October 2, 2021

Nine Months Ended September 26, 2020



(In thousands)


HDD

DCP

PV

ASP

Total

HDD

PV

Total


Systems, upgrades and spare parts
   $ 14,034    $ 3    $ 219    $ 3,850    $ 18,106    $ 29,189    $ 400    $ 29,589
Field service
   4,425    14    60    0      4,499    4,334    2    4,336
















Total TFE net revenues
   $ 18,459    $ 17    $ 279    $ 3,850    $ 22,605    $ 33,523    $ 402    $ 33,925

Three Months Ended

Nine Months Ended


Photonics

October 2,

2021

September 26,

2020

October 2,

2021

September 26,

2020



(In thousands)

Products:

Military products
   $ 3,343    $ 4,947    $ 11,552    $ 15,758
Commercial products
   100    139    278    257
Repair and other services
   259    574    975    1,649








Total Photonics product net revenues
   3,702    5,660    12,805    17,664
Technology development:

Firm Fixed Price (“FFP”)
   1,571    5,482    4,919    15,374
Cost Plus Fixed Fee (“CPFF”)
   1,522    1,056    4,518    2,285








Total technology development net revenues
   3,093    6,538    9,437    17,659








Total Photonics net revenues
   $ 6,795    $ 12,198    $ 22,242    $ 35,323


	Six Months Ended July 2, 2022								Six Months Ended July 3, 2021


	(In thousands)
	HDD		DCP		PV		Total		HDD		DCP		PV		ASP		Total

Systems, upgrades and spare parts	$	10,879	$	1	$	135	$	11,015	$	7,539	$	3	$	158	$	3,850	$	11,550
Field service		2,684		43		10		2,737		3,001		14		42		—		3,057

Total net revenues	$	13,563	$	44	$	145	$	13,752	$	10,540	$	17	$	200	$	3,850	$	14,607

Primary Geographical Markets


	Three Months Ended						Three Months Ended
													Three Months Ended				Six Months Ended
	October 2, 2021						September 26, 2020
													July 2, 2022		July 3, 2021		July 2, 2022		July 3, 2021
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total		(In thousands)
United States	$	220	$	6,738	$	6,958	$	1,764	$	12,079	$	13,843	$	1,656	$	2,121	$	1,950	$	2,488
Asia		7,778		0		7,778		7,536		0		7,536		7,651		3,248		11,802		8,269
Europe		0		57		57		67		119		186		—		—		—		3,850

Total net revenues	$	7,998	$	6,795	$	14,793	$	9,367	$	12,198	$	21,565	$	9,307	$	5,369	$	13,752	$	14,607

Nine Months Ended

Nine Months Ended



October 2, 2021

September 26, 2020



(In thousands)


TFE

Photonics

Total

TFE

Photonics

Total

United States
   $ 2,708    $ 22,069    $ 24,777    $ 2,596    $ 35,060    $ 37,656
Asia
   16,047    0      16,047    31,262    0      31,262
Europe
   3,850    173    4,023    67    263    330












Total net revenues
   $ 22,605    $ 22,242    $ 44,847    $ 33,925    $ 35,323    $ 69,248

~~Table of Contents~~

~~INTEVAC, INC.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)~~

~~(Unaudited)~~

Timing of Revenue Recognition


	Three Months Ended						Three Months Ended
													Three Months Ended				Six Months Ended
	October 2, 2021						September 26, 2020
													July 2, 2022		July 3, 2021		July 2, 2022		July 3, 2021
	(In thousands)
	TFE		Photonics		Total		TFE		Photonics		Total		(In thousands)
Products transferred at a point in time	$	7,998	$	259	$	8,257	$	9,367	$	574	$	9,941	$	9,307	$	5,369	$	13,752	$	14,607
Products and services transferred over time		0		6,536		6,536		0		11,624		11,624		—		—		—		—

Total net revenues													$	9,307	$	5,369	$	13,752	$	14,607
	$	7,998	$	6,795	$	14,793	$	9,367	$	12,198	$	21,565

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Nine Months Ended

Nine Months Ended



October 2, 2021

September 26, 2020



(In thousands)


TFE

Photonics

Total

TFE

Photonics

Total

Products transferred at a point in time
   $ 22,605    $ 574    $ 23,179    $ 33,925    $ 1,649    $ 35,574
Products and services transferred over time
   0      21,668    21,668    0      33,674    33,674












   $ 22,605    $ 22,242    $ 44,847    $ 33,925    $ 35,323    $ 69,248

The following table reflects the changes in our contract assets, which we classify as accounts receivable, unbilled ~~or retainage,~~ and our contract liabilities, which we classify as deferred revenue and customer advances, for the ~~nine~~six months ended ~~October~~July 2, ~~2021:~~2022:


	October 2, 2021		January 2, 2021		Nine Months Change			July 2, 2022		January 1, 2022		Six Months Change

	(In thousands)							(In thousands)
TFE:
Contract assets:
Accounts receivable, unbilled	$	0	$	369	$	(369	)	$	—	$	99	$	(99	)

Contract liabilities:
Deferred revenue	$	197	$	482	$	(285	)	$	129	$	65	$	64
Customer advances		24		33		(9	)		24,760		2,107		22,653

	$	221	$	515	$	(294	)	$	24,889	$	2,172	$	22,717


Photonics:
Contract assets:
Accounts receivable, unbilled	$	1,493	$	5,439	$	(3,946	)
Retainage		87		126		(39	)

	$	1,580	$	5,565	$	(3,985	)

Contract liabilities:
Deferred revenue	$	550	$	779	$	(229	)

Accounts receivable, unbilled ~~in our TFE segment~~ represents a contract asset for revenue that has been recognized in advance of billing the customer. For our system and certain upgrade sales, our ~~TFE~~ customers generally pay in 3 installments, with a portion of the system price billed upon receipt of an order, a portion of the price billed upon shipment, and the balance of the price due upon completion of installation and acceptance of the system at the customer’s factory. Accounts receivable, unbilled ~~in our TFE segment~~ generally represents the balance of the system price that is due upon completion of installation and acceptance, less, the amount that has been deferred as revenue for the performance of the installation tasks. During the ~~nine~~six months ended ~~October~~July 2, ~~2021,~~2022, contract assets ~~in our TFE segment~~ decreased by ~~$369,000~~$99,000 primarily due to the ~~recognition~~billing of accrued revenue ~~for the installation portion~~related to spare parts sold to a customer as of ~~revenue for one system that completed installation and acceptance.~~

~~Table of Contents~~

~~INTEVAC, INC.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)~~

~~(Unaudited)~~

January 1, 2022.

Customer advances ~~in our TFE segment~~ generally represent a contract liability for amounts billed to the customer prior to transferring goods. The Company has elected to use the practical expedient to disregard the effect of the time value of money in a significant financing component when its payment terms are less than one year. These ~~contract~~customer advances are liquidated when revenue is recognized. Deferred revenue ~~in our TFE segment~~ generally represents a contract liability for amounts billed to a customer for completed systems at the customer site that are undergoing installation and acceptance testing where transfer of control has not yet occurred as Intevac does not yet have a demonstrated history of meeting the acceptance criteria upon the customer’s receipt of product. During the ~~nine~~six months ended ~~October~~July 2, ~~2021,~~2022, we recognized revenue ~~in our TFE segment~~ of ~~$33,000~~$353,000 and ~~$296,000~~$39,000 that was included in customer advances and deferred revenue, respectively, at the beginning of the period.

Accounts receivable, unbilled in our Photonics segment represents a contract asset for revenue that has been recognized in advance of billing the customer, which is common for contracts in the defense industry. In our Photonics segment, amounts are billed as work progresses in accordance with agreed-upon contractual terms, either at periodic intervals (e.g., monthly) or upon achievement of contractual milestones. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets. Our contracts with the U.S. government may also contain retainage provisions. Retainage represents a contract asset for the portion of the contract price earned by us for work performed but held for payment by the U.S. government as a form of security until satisfactory completion of the contract. The retainage is billable upon completion of the contract performance and approval of final indirect expense rates by the government. During the nine months ended OctoberOn July 2, 2021, contract assets in our Photonics segment decreased by $4.0 million primarily due to the billing of contractual milestones, offset in part by the accrual of revenue for incurred costs under FFP and CPFF contracts.

Deferred revenue in our Photonics segment generally represents a contract liability for amounts billed to the customer upon achievement of contractual milestones. These amounts are liquidated when revenue is recognized. During the nine months ended October 2, 2021, we recognized revenue in our Photonics segment of $779,000 that was included in deferred revenue at the beginning of the period.

~~On October 2, 2021,~~2022, we had ~~$44.9~~$100.2 million of remaining performance obligations, which we also refer to as ~~backlog. Backlog at October 2, 2021 consisted of $16.9 million of TFE backlog and $27.9 million of Photonics~~total backlog. We expect to recognize approximately ~~38%~~22% of our remaining performance obligations as revenue in ~~2021, 40% in~~ 2022, ~~21%~~26% in 2023, 26% in 2024 and 1%26% in ~~2024.~~2025.

3.4.	Inventories

Inventories are stated at the lower of average cost or net realizable value and consist of the following:

October 2,

January 2,


2021

2021



(In thousands)

Raw materials
   $ 11,262    $ 9,999
Work-in-progress
   6,929    4,832
Finished goods
   4,262    6,858




   $ 22,453    $ 21,689

Finished goods inventory at October 2, 2021 included one VERTEX SPECTRA system for DCP at a customer’s factory previously under evaluation for which the evaluation period has ended but the tool is being considered for another application at that site. Finished goods inventory at January 2, 2021 included one VERTEX SPECTRA system for DCP under evaluation at a customer’s factory and one MATRIX PVD system for advanced semiconductor packaging under evaluation at a customer’s factory.


	July 2, 2022		January 1, 2022

	(In thousands)
Raw materials	$	6,728	$	5,323
Work-in-progress		5,043		468

	$	11,771	$	5,791

4.5.	Equity-Based Compensation

At ~~October~~July 2, ~~2021,~~2022, Intevac had equity-based awards outstanding under the 2020 Equity Incentive Plan, ~~and~~ the 2012 Equity Incentive Plan, the 2022 Inducement Equity Incentive Plan (the “Inducement Plan”) (together, the “Plans”) and the 2003 Employee Stock Purchase Plan (the “ESPP”). Intevac’s stockholders approved ~~all of these plans.~~the 2020 Equity Incentive Plan, the 2012 Equity Incentive Plan and the ESPP. The Plans permit the grant of incentive or

non-statutory

stock options, performance-based stock options (“PSOs”), restricted stock, stock appreciation rights, restricted stock units (“RSUs”), performance-based restricted stock units (“PRSUs”) and performance shares.

On January 19, 2022, Intevac’s Board of Directors adopted the Inducement Plan and, subject to the adjustment provisions of the

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Inducement Plan, reserved 1,200,000 shares of the Company’s common stock for issuance pursuant to equity awards granted under the Inducement Plan. The Inducement Plan provides for the grant of equity-based awards, including nonstatutory stock options, restricted stock units, restricted stock, stock appreciation rights, performance shares and performance units, and its terms are substantially similar to the Company’s 2020 Equity Incentive Plan. The Inducement Plan was adopted without stockholder approval pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. In accordance with that rule, awards under the Inducement Plan may only be made to individuals not previously employees or

non-employee

directors of the Company (or following such individuals’ bona fide period of

non-employment

with the Company), as an inducement material to the individuals’ entry into employment with the Company.

The ESPP provides that eligible employees may purchase Intevac’s common stock through payroll deductions at a price equal to 85% of the lower of the fair market value at the entry date of the applicable offering period or at the end of each applicable purchase interval. Offering periods are generally two years in length and consist of a series of

six-month

purchase intervals. Eligible employees may join the ESPP at the beginning of any

six-month

purchase interval. Under the terms of the ESPP, employees can choose to have up to 50% of their base earnings withheld to purchase Intevac common stock (not to exceed $25,000 per year).

~~Equity-based~~ Compensation Expense

The effect of recording equity-based compensation for the three and ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 and ~~September 26, 2020~~July 3, 2021 was as follows:


	Three Months Ended				Nine Months Ended				Three Months Ended				Six Months Ended

	October 2, 2021		September 26, 2020		October 2, 2021		September 26, 2020		July 2, 2022		July 3, 2021		July 2, 2022			July 3, 2021

	(In thousands)								(In thousands)
Equity-based compensation by type of award:
Stock options	$	27	$	47	$	159	$	411	$	8	$	57	$	(163	)	$	132
RSUs		673		495		1,872		1,311		1,295		656		567			1,200
ESPP awards		185		316		841		464
ESPP purchase rights										222		306		85			655

Total equity-based compensation	$	885	$	858	$	2,872	$	2,186	$	1,525	$	1,019	$	489		$	1,987

Included in the table above are:

(a)

A reversal of $1.3 million in equity-based compensation expense related to forfeitures of awards due to our reduction in workforce and a $37,000 benefit related to the modification of certain stock-based awards for the six months ended July 2, 2022. (See Note

13. Restructuring and Other Costs, Net.); and

(b)

Equity-based compensation reported in discontinued operations of $39,000 and ($291,000) for the three and six months ended July

2, 2022, respectively, and $247,000 and $518,000 for the three and six months ended July 3, 2021, respectively. Equity-based compensation expense allocated to discontinued operations for the six months ended July 2, 2022 includes $75,000 related to the modification of certain stock-based awards and is net of a divestiture-related forfeiture benefit of $446,000 that was recognized when employees were conveyed to the Buyer upon closing. (See Note 2. Divestiture and Discontinued Operations.)

Stock Options and ESPP

The fair value of stock options and ESPP awards is estimated at the grant date using the Black-Scholes option valuation model. The determination of fair value of stock options and ESPP awards on the date of grant using an option-pricing model is affected by Intevac’s stock price as well as assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, our expected stock price volatility over the term of the awards, and actual employee stock option exercise behavior. Intevac accounts for forfeitures as they occur, rather than estimating expected forfeitures.

Option activity as of ~~October~~July 2, ~~2021~~2022 and changes during the ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 were as follows:

Shares

Weighted-Average

Exercise Price


Options outstanding at January 2, 2021
   1,814,467    $ 6.66
Options granted
   0—      $ 0—
Options cancelled and forfeited
   (211,042 )    $ 7.47
Options exercised
   (73,744 )    $ 5.89



Options outstanding at October 2, 2021
   1,529,681    $ 6.57



Options exercisable at October 2, 2021
   1,317,356    $ 6.78

~~Intevac issued 434,054 shares of common stock under the ESPP during the nine months ended October 2, 2021.~~

~~Intevac estimated the weighted-average fair value of stock options and employee stock purchase rights using the following weighted-average assumptions:~~

Three Months Ended

Nine Months Ended



October 2,
2021

September 26,
2020

October 2,
2021

September 26,
2020


Stock Options:

Weighted-average fair value of grants per share
   $ 0      $ 0      $ 0      $ 1.82
Expected volatility
   0      0      0      46.04 %
Risk-free interest rate
   0      0      0      0.44 %
Expected term of options (in years)
   —      —      —    4.39
Dividend yield
   0      0      0      NaN


	Shares			Weighted-Average Exercise Price

Options outstanding at January 1, 2022		1,457,587		$	6.55
Options cancelled and forfeited		(550,332	)	$	7.31
Options exercised		(313,000	)	$	4.83

Options outstanding at July 2, 2022		594,255		$	6.76

Options exercisable at July 2, 2022		564,979		$	6.82

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Three Months Ended

Nine Months Ended



October 2,
2021

September 26,
2020

October 2,
2021

September 26,
2020


Stock Purchase Rights:

Weighted-average fair value of grants per share
   $ 2.43 $ 2.20 $ 2.59 $ 2.20
Expected volatility
   64.94 % 51.72 % 60.88 % 51.49 %
Risk-free interest rate
   0.07 % 0.12 % 0.08 % 0.14 %
Expected term of purchase rights (in years)
   0.75 1.26 0.91 1.24
Dividend yield
   NaN NaN NaN NaN

Intevac issued 146,344 shares of common stock under the ESPP during the six months ended July 2, 2022.

Intevac estimated the weighted-average fair value of ESPP purchase rights using the following weighted-average assumptions:


	Six Months Ended
	July 2, 2022			July 3, 2021

ESPP Purchase Rights:
Weighted-average fair value of grants per share	$	1.85		$	2.69
Expected volatility		60.36	%		58.56	%
Risk-free interest rate		0.98	%		0.08	%
Expected term of purchase rights (in years)		1.2			1.0
Dividend yield		NaN			NaN

The computation of the expected volatility assumptions used in the Black-Scholes calculations for ~~new stock option grants and~~ ESPP purchase rights is based on the historical volatility of Intevac’s stock price, measured over a period equal to the expected term of the ~~stock option grant or~~ purchase right. The risk-free interest rate is based on the yield available on U.S. Treasury Strips with an equivalent remaining term. The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the equity-based awards and vesting schedules. The expected term of purchase rights represents the period of time remaining in the current offering period. The dividend yield assumption is based on Intevac’s history of not paying dividends and the assumption of not paying dividends in the future.

RSUs

RSU activity as of ~~October~~July 2, ~~2021~~2022 and changes during the ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 were as follows:


	Shares			Weighted-Average Grant Date Fair Value		Shares			Weighted-Average Grant Date Fair Value

Non-vested RSUs at January 2, 2021		901,634		$	5.30
Non-vested RSUs at January 1, 2022							1,033,436		$	5.59
Granted		590,931		$	6.18		1,756,267		$	4.36
Vested		(301,305	)	$	6.07		(211,889	)	$	5.47
Cancelled and forfeited		(82,529	)	$	4.66		(533,199	)	$	5.65

Non-vested RSUs at October 2, 2021		1,108,731		$	5.60
Non-vested RSUs at July 2, 2022							2,044,615		$	4.53

Time-based RSUs are converted into shares of Intevac common stock upon vesting on a

one-for-one

basis. Time-based RSUs typically are scheduled to vest overthree or four years. Vesting of time-based RSUs is subject to the grantee’s continued service with Intevac. The compensation expense related to these awards is determined using the fair market value of Intevac common stock on the date of the grant, and the compensation expense is recognized over the vesting period.

In May 2022, we granted to members of our senior management awards of performance-based restricted stock units (“PRSU Awards”) covering an aggregate of 935,600 shares of Intevac common stock (at maximum performance). The PRSU Awards are eligible to be earned based on achievement of certain stock prices based on the average closing price of the Company’s stock over a

30-day

period (the “Company Stock Price Hurdle”) during a three-year performance period commencing on May 18, 2022 and ending on May 31, 2025 (or earlier, upon a change in control, as defined in the Company’s 2022 Inducement Equity Incentive Plan or 2020 Equity Incentive Plan, as applicable) (the “Performance Period”). The PRSU Awards will vest, if at all, in five possible tranches. Each of the five tranches will vest only if the applicable Company Stock Price Hurdle is achieved within the Performance Period, and each tranche may only be achieved once during the Performance Period. If a Company Stock Price Hurdle is not achieved within the Performance Period, the corresponding PRSUs will not vest, and all unvested PRSUs at the end of the Performance Period will immediately be forfeited. The fair value of each PRSU award was estimated on the date of grant using a Monte Carlo simulation. PRSU Award activity is included in the above RSU tables.

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Intevac estimated the weighted-average fair value of the PRSU Awards granted in May 2022 using the following weighted-average assumptions:


	Three Months Ended
	July 2, 2022
Weighted-average fair value of grants per share	$	3.67
Expected volatility		54.42	%
Risk-free interest rate		2.82	%
Dividend yield		NaN

In May 2021, we granted ~~126,320 performance-based restricted stock units (“PRSUs”)~~ to members of our senior ~~management.~~management PRSU Awards covering an aggregate of 126,320 shares of Intevac common stock (at

target

performance). The number of PRSUs that will vest is determined by our common stock achieving a certain Total Shareholder Return (“TSR”) for the Company, relative to the TSR of a specified peer group over a measurement period of two years from the time of grant. The fair value of each PRSU ~~award~~Award was estimated on the date of grant using a Monte Carlo simulation. PRSU Award activity is included in the above RSU tables. At the end of the performance measurement period, the Compensation Committee of the Company’s Board of Directors ~~(the “Compensation Committee”)~~ will determine the achievement against the performance objectives. Depending on the Company’s TSR relative to the peer group TSR, the actual number of shares that will be vested for each PRSU ~~grant~~Award can range from ~~zero~~0 to 200% of the initial grant.

Intevac estimated the weighted-average fair value of ~~PRSUs~~the PRSU Awards granted in May 2021 using the following weighted-average assumptions:

Nine Months Ended


October 2, 2021

Weighted-average fair value of grants per share
   $ 7.65
Expected volatility
   56.26 %
Risk-free interest rate
   0.15 %
Dividend yield
   NaN

~~Table of Contents~~

~~INTEVAC, INC.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)~~

~~(Unaudited)~~

~~In May 2020, we granted 109,465 PRSUs to members of our senior management. The PRSUs were issued collectively in four separate tranches with individual~~

~~one-year~~

performance periods beginning in May 2020, 2021, 2022 and 2023, respectively. Vesting of the PRSUs is based on the performance of our common stock relative to the performance of a specified peer group. The fair value of each PRSU award was estimated on the date of grant using a Monte Carlo simulation. PRSU activity is included in the above RSU tables. At the end of each performance measurement period, the Compensation Committee will determine the achievement against the performance objectives. Any earned PRSU awards will vest 100% after the end of the applicable performance measurement period. The first performance measurement period ended in May 2021 and the metric was not achieved and 27,366 PRSUs were cancelled.

~~Intevac estimated the weighted-average fair value of PRSUs using the following weighted-average assumptions:~~


	Nine Months Ended			Three Months Ended
	September 26, 2020			July 3, 2021
Weighted-average fair value of grants per share	$	3.16		$	7.65
Expected volatility		46.7	%		56.26	%
Risk-free interest rate		0.25	%		0.15	%
Dividend yield		NaN			NaN

5.6.

Warranty

Intevac provides for the estimated cost of warranty when revenue is recognized. Intevac’s warranty is subject to contract terms and, for its HDD manufacturing, DCP manufacturing, solar cell manufacturing and advanced semiconductor packaging ~~manufacturing~~ systems, the warranty typically ranges between 12 and 24 months from customer acceptance. During this warranty period any defective

non-consumable

parts are replaced and installed at no charge to the customer. Intevac uses estimated repair or replacement costs along with its historical warranty experience to determine its warranty obligation. The provision for the estimated future costs of warranty is based upon historical cost and product performance experience. Intevac exercises judgment in determining the underlying estimates.

On the condensed consolidated balance sheets, the short-term portion of the warranty provision is included in other accrued liabilities, while the long-term portion is included in other long-term liabilities. The expense associated with product warranties issued or adjusted is included in cost of net revenues on the condensed consolidated statements of operations.

~~The following table displays the activity in the warranty provision account for the three and nine months ended October 2, 2021 and September 26, 2020:~~

Three Months Ended

Nine Months Ended



October 2,

2021

September 26,

2020

October 2,

2021

September 26,

2020



(In thousands)

Opening balance
   $ 572    $ 662    $ 480    $ 1,022
Expenditures incurred under warranties
   (148 )    (89 )    (564 )    (398 )
Accruals for product warranties issued during the reporting period
   80    39    553    198
Adjustments to previously existing warranty accruals
   106    (57 )    141    (267 )








Closing balance
   $ 610    $ 555    $ 610    $ 555

~~The following table displays the balance sheet classification of the warranty provision account at October 2, 2021 and at January 2, 2021:~~

October 2,

2021

January 2,

2021



(In thousands)

Other accrued liabilities
   $ 542    $ 405
Other long-term liabilities
   68    75




Total warranty provision
   $ 610    $ 480

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

The following table displays the activity in the warranty provision account for the three and six months ended July 2, 2022 and July 3, 2021:


	Three Months Ended						Six Months Ended

	July 2, 2022			July 3, 2021			July 2, 2022			July 3, 2021

				(In thousands)
Opening balance	$	249		$	590		$	346		$	480
Expenditures incurred under warranties		(54	)		(195	)		(225	)		(346	)
Expenditures incurred under warranties included in discontinued operations		—			(22	)		—			(69	)
Accruals for product warranties issued during the reporting period		36			155			72			410
Accruals for product warranties issued during the reporting period included in discontinued operations		—			43			—			63
Adjustments to previously existing warranty accruals		(17	)		(15	)		21			(25	)
Adjustments to previously existing warranty accruals included in discontinued operations		—			16			—			59

Closing balance	$	214		$	572		$	214		$	572

The following table displays the balance sheet classification of the warranty provision account at July 2, 2022 and at January 1, 2022.


	July 2 2022		January 1 2022

	(In thousands)
Other accrued liabilities	$	199	$	301
Other long-term liabilities		15		45

Total warranty provision	$	214	$	346

6.7.	Guarantees

Officer and Director Indemnifications

As permitted or required under Delaware law and to the maximum extent allowable under that law, Intevac has certain obligations to indemnify its current and former officers and directors for certain events or occurrences while the officer or director is, or was, serving at Intevac’s request in such capacity. These indemnification obligations are valid as long as the director or officer acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the Company and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. The maximum potential amount of future payments Intevac could be required to make under these indemnification obligations is unlimited; however, Intevac has a director and officer insurance policy that mitigates Intevac’s exposure and enables Intevac to recover a portion of any future amounts paid. As a result of Intevac’s insurance policy coverage, Intevac believes the estimated fair value of these indemnification obligations is not material.

Other Indemnifications

As is customary in Intevac’s industry, many of Intevac’s contracts provide remedies to certain third parties such as defense, settlement, or payment of judgments for intellectual property claims related to the use of its products. Such indemnification obligations may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.

Letters of Credit

As of ~~October~~July 2, ~~2021,~~2022, we had letters of credit and bank guarantees outstanding totaling $786,000, including the standby letter of credit outstanding under the Santa Clara, California facility lease and various other guarantees with our bank. These letters of credit and bank guarantees are collateralized by $786,000 of restricted cash.

7.8.	Cash, Cash Equivalents and Investments

Cash and cash equivalents, short-term investments and long-term investments consist of:

October 2, 2021



Amortized Cost

Unrealized
Holding

Gains

Unrealized
Holding

Losses

Fair Value



(In thousands)

Cash and cash equivalents:

Cash
   $ 28,749    $ —      $ —      $ 28,749
Money market funds
   4,447    —      —      4,447
Municipal bonds
   500    —      —      500








Total cash and cash equivalents
   $ 33,696    $ —      $ —      $ 33,696
Short-term investments:

Certificates of deposit
   $ 6,299    $ 3    $ —      $ 6,302
Commercial paper
   400    —      —      400
Corporate bonds and medium-term notes
   2,919    1    —      2,920
Municipal bonds
   515    —      —      515
U.S. treasury and agency securities
   1,000    —      —      1,000








Total short-term investments
   $ 11,133    $ 4    $ —      $ 11,137
Long-term investments:

Asset backed securities
   $ 480    $ —      $ —      $ 480
Certificates of deposit
   500    —      1    499
Corporate bonds and medium-term notes
   2,541    1    1    2,541
Municipal bonds
   145    —      1    144
U.S. treasury and agency securities
   2,161    —      —      2,161








Total long-term investments
   $ 5,827    $ 1    $ 3    $ 5,825








Total cash, cash equivalents, and investments
   $ 50,656    $ 5    $ 3    $ 50,658

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

January 2, 2021



Amortized Cost

Unrealized
Holding
Gains

Unrealized
Holding
Losses

Fair Value



(In thousands)

Cash and cash equivalents:

Cash
   $ 24,729    $ —      $ —      $ 24,729
Money market funds
   3,612    —      —      3,612
Certificates of deposit
   1,000    —      —      1,000








Total cash and cash equivalents
   $ 29,341    $ —      $ —      $ 29,341
Short-term investments:

Certificates of deposit
   $ 6,450    $ 2    $ 0      $ 6,452
Commercial paper
   500    0      0      500
Corporate bonds and medium-term notes
   2,929    6    0      2,935
Municipal bonds
   400    —      —      400
U.S. treasury and agency securities
   4,527    25    0      4,552








Total short-term investments
   $ 14,806    $ 33    $ 0      $ 14,839
Long-term investments:

Certificates of deposit
   $ 500    $ 0      $ 0      $ 500
Corporate bonds and medium-term notes
   3,474    4    0      3,478
U.S. treasury and agency securities
   1,409    1    0      1,410








Total long-term investments
   $ 5,383    $ 5    $ 0      $ 5,388








Total cash, cash equivalents, and investments
   $ 49,530    $ 38    $ 0      $ 49,568

~~The contractual maturities of~~

~~available-for-sale~~

~~securities at October 2, 2021 are presented in the following table.~~

October 2, 2021


Amortized

Cost

Fair Value



(In thousands)

Due in one year or less
   $ 16,080    $ 16,084
Due after one through three years
   5,827    5,825




   $ 21,907    $ 21,909

~~The following table provides the fair market value of Intevac’s investments with unrealized losses that are not deemed to be other-than temporarily impaired as of October 2, 2021.~~


	July 2, 2022
	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value

	(In thousands)
Cash and cash equivalents:
Cash	$	46,732	$	—	$	—	$	46,732
Money market funds		3,591		—		—		3,591
Commercial paper		3,348		—		2		3,346

Total cash and cash equivalents	$	53,671	$	—	$	2	$	53,669
Short-term investments:
Asset backed securities	$	1,003	$	—	$	2	$	1,001
Certificates of deposit		7,850		—		23		7,827
Commercial paper		14,586		2		37		14,551
Corporate bonds and medium-term notes		4,725		—		52		4,673
Municipal bonds		493		—		7		486
U.S. treasury securities		2,661		—		31		2,630

Total short-term investments	$	31,318	$	2	$	152	$	31,168
Long-term investments:
Asset backed securities	$	9,876	$	—	$	80	$	9,796
Corporate bonds and medium-term notes		5,204		7		32		5,179
Municipal bonds		1,212		—		9		1,203
U.S. treasury and agency securities		8,486		—		99		8,387

Total long-term investments	$	24,778	$	7	$	220	$	24,565

Total cash, cash equivalents, and investments	$	109,767	$	9	$	374	$	109,402


	October 2, 2021								January 1, 2022
	In Loss Position for Less than 12 Months				In Loss Position for Greater than 12 Months				Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value

	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses		(In thousands)
Cash and cash equivalents:
Cash									$	102,494	$	—	$	—	$	102,494
Money market funds										234		—		—		234

Total cash and cash equivalents									$	102,728	$	—	$	—	$	102,728
Short-term investments:
Certificates of deposit									$	4,300	$	—	$	—	$	4,300
Commercial paper										400		—		—		400
Corporate bonds and medium-term notes										2,916		—		3		2,913
Municipal bonds										700		—		—		700
U.S. treasury securities										1,910		—		2		1,908
	(In thousands)
Total short-term investments									$	10,226	$	—	$	5	$	10,221
Long-term investments:
Asset backed securities									$	2,040	$	—	$	3	$	2,037
Certificates of deposit	$	499	$	1	$	0	$	0		500		—		3		497
Corporate bonds and medium-term notes		1,944		1		0		0		1,521		—		6		1,515
Municipal bond		145		1		0		0
Municipal bonds										145		—		1		144
U.S. treasury securities										3,246		—		12		3,234

Total long-term investments									$	7,452	$	—	$	25	$	7,427
	$	2,588	$	3	$	0	$	0
Total cash, cash equivalents, and investments									$	120,406	$	—	$	30	$	120,376

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

The contractual maturities of investment securities at July 2, 2022 are presented in the following table.


	Amortized Cost		Fair Value

	(In thousands)
Due in one year or less	$	38,257	$	38,105
Due after one through five years		24,778		24,565

	$	63,035	$	62,670

The following table provides the fair market value of Intevac’s investments with unrealized losses that are not deemed to be other-than temporarily impaired as of July 2, 2022.


	July 2, 2022
	In Loss Position for Less than 12 Months				In Loss Position for Greater than 12 Months
	Fair Value		Gross Unrealized Losses		Fair Value		Gross Unrealized Losses

	(In thousands)
Asset backed securities	$	10,180	$	82	$	—	$	—
Certificates of deposit		6,827		23		—		—
Commercial paper		15,932		39		—		—
Corporate bonds and medium-term notes		8,345		80		500		4
Municipal bonds		1,698		16		—		—
U.S. treasury and agency securities		11,017		130		—		—

	$	53,990	$	370	$	500	$	4

All prices for the fixed maturity securities including U.S. ~~Treasury~~treasury and agency securities, certificates of deposit, commercial paper, corporate bonds, asset backed securities and municipal bonds are received from independent pricing services utilized by Intevac’s outside investment manager. This investment manager performs a review of the pricing methodologies and inputs utilized by the independent pricing services for each asset type priced by the vendor. In addition, on at least an annual basis, the investment manager conducts due diligence visits and interviews with each pricing vendor to verify the inputs utilized for each asset class. The due diligence visits include a review of the procedures performed by each vendor to ensure that pricing evaluations are representative of the price that would be received ~~for~~if a security were sold in an orderly ~~sale.~~transaction. Any pricing where the input is based solely on a broker price is deemed to be a Level 3 price. Intevac uses the pricing data obtained from its outside investment manager as the primary input to make its assessments and determinations as to the ultimate valuation of the above-mentioned securities and has not made, during the periods presented, any material adjustments to such inputs.

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

The following table represents the fair value hierarchy of Intevac’s

~~available-for-sale~~

investment securities measured at fair value on a recurring basis as of ~~October~~July 2, ~~2021.~~2022.

Fair Value Measurements

at October 2, 2021



Total

Level 1

Level 2



(In thousands)

Recurring fair value measurements:

Available-for-sale
securities

Money market funds
   $ 4,447    $ 4,447    $ —
U.S. treasury and agency securities
   3,161    3,161    —
Asset backed securities
   480    —      480
Certificates of deposit
   6,801    —      6,801
Commercial paper
   400    —      400
Corporate bonds and medium-term notes
   5,461    —      5,461
Municipal bonds
   1,159    —      1,159






Total recurring fair value measurements
   $ 21,909    $ 7,608    $ 14,301


	Fair Value Measurements at July 2, 2022
	Total		Level 1		Level 2

	(In thousands)
Recurring fair value measurements:
Investment securities
Money market funds	$	3,591	$	3,591	$	—
U.S. treasury and agency securities		11,017		7,521		3,496
Asset backed securities		10,797		—		10,797
Certificates of deposit		7,827		—		7,827
Commercial paper		17,897		—		17,897
Corporate bonds and medium-term notes		9,852		—		9,852
Municipal bonds		1,689		—		1,689

Total recurring fair value measurements	$	62,670	$	11,112	$	51,558

9. Derivative Instruments

The Company uses foreign currency forward contracts to mitigate variability in gains and losses generated from the

re-measurement

of certain monetary assets and liabilities denominated in foreign currencies and to offset certain operational exposures from the impact of changes in foreign currency exchange rates. These derivatives are carried at fair value with changes recorded in interest income and other income (expense), net in the condensed consolidated statements of operations. Changes in the fair value of these derivatives are largely offset by

re-measurement

of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. The derivatives have ~~original~~ maturities of approximately 30 days.

The following table summarizes the Company’s outstanding derivative instruments on a gross basis as recorded in its condensed consolidated balance sheets as of ~~October~~July 2, ~~2021~~2022 and January ~~2, 2021:~~1, 2022.

Notional Amounts

Derivative Liabilities

Derivative Instrument

October 2

2021

January 2,

2021

October 2,

2021

January 2,

2021



Balance

Sheet

Line

Fair

Value

Balance

Sheet

Line

Fair

Value



(In thousands)

Undesignated Hedges:

Forward Foreign Currency Contracts
   $ 811    $ 983    (a ) $ 2    (a ) $ 3








Total Hedges
   $ 811    $ 983    $ 2    $ 3


	Notional Amounts				Derivative Liabilities				Derivative Assets
Derivative Instrument	July 2, 2022		January 1, 2022		July 2, 2022				January 1, 2022
					Balance Sheet Line		Fair Value		Balance Sheet Line		Fair Value
	(In thousands)
Undesignated Hedges:
Forward Foreign Currency Contracts	$	1,074	$	815		(b)	$	11		(a)	$	14

Total Hedges	$	1,074	$	815			$	11			$	14

(a)	Other current assets

(b)	Other accrued liabilities

~~Table of Contents~~

~~INTEVAC, INC.~~

10. Equity

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)~~Stock Repurchase Program

~~(Unaudited)~~

9.	~~Equity~~

~~Condensed Consolidated Statement~~On November 21, 2013, Intevac announced that its Board of ~~Changes~~Directors approved a stock repurchase program authorizing up to $30.0 million in ~~Equity~~

~~The changes in stockholders’ equity by component~~repurchases. On August 20, 2018, Intevac’s Board of Directors approved a $10.0 million increase to the original stock repurchase program for an aggregate authorized amount of up to $40.0 million. At July 2, 2022, $10.4 million remains available for future stock repurchases under the repurchase program. Intevac did not make any common stock repurchases during the three and ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 and ~~September 26, 2020, are as follows (in thousands):~~July 3, 2021.

Three months ended October 2, 2021


Common
Stock and
Additional
Paid-in

Capital

Treasury
Stock

Accumulated
Other
Comprehensive
Income

Accumulated
Deficit

Total
Stockholders’
Equity


Balance at July 3, 2021
   $ 196,088 $ (29,551 ) $ 571 $ (75,360 ) $ 91,748
Common stock issued under employee plans
   1,182 —   —   —   1,182
Shares withheld for net share settlement of RSUs
   (13 ) —   —   —   (13 )
Equity-based compensation expense
   885 —   —   —   885
Net loss
   —   —   —   (4,233 ) (4,233 )
Other comprehensive loss
   —   —   (14 ) —   (14 )


Balance at October 2, 2021
   $ 198,142 $ (29,551 ) $ 557 $ (79,593 ) $ 89,555

Nine months ended October 2, 2021


Common
Stock and
Additional
Paid-in

Capital

Treasury
Stock

Accumulated
Other
Comprehensive
Income

Accumulated
Deficit

Total
Stockholders’
Equity


Balance at January 2, 2021
   $ 193,197 $ (29,551 ) $ 640 $ (62,730 ) $ 101,556
Common stock issued under employee plans
   2,618 —   —   —   2,618
Shares withheld for net share settlement of RSUs
   (545 ) —   —   —   (545 )
Equity-based compensation expense
   2,872 —   —   —   2,872
Net loss
   —   —   —   (16,863 ) (16,863 )
Other comprehensive loss
   —   —   (83 ) —   (83 )


Balance at October 2, 2021
   $ 198,142 $ (29,551 ) $ 557 $ (79,593 ) $ 89,555

Three months ended September 26, 2020


Common
Stock and
Additional
Paid-in

Capital

Treasury
Stock

Accumulated
Other
Comprehensive
Income

Accumulated
Deficit

Total
Stockholders’
Equity


Balance at June 27, 2020
   $ 190,290 $ (29,551 ) $ 402    $ (63,486 ) $ 97,655
Common stock issued under employee plans
   871 —   —      —   871
Shares withheld for net share settlement of RSUs
   (19 ) —   —      —   (19 )
Equity-based compensation expense
   858 —   —      —   858
Net loss
   —   —   —      (357 ) (357 )
Other comprehensive income
   —   —   100    —   100




Balance at September 26, 2020
   $ 192,000 $ (29,551 ) $ 502    $ (63,843 ) $ 99,108

Nine months ended September 26, 2020


Common
Stock and
Additional
Paid-in

Capital

Treasury
Stock

Accumulated
Other
Comprehensive
Income

Accumulated
Deficit

Total
Stockholders’
Equity


Balance at December 28, 2019
   $ 188,313 $ (29,158 ) $ 424    $ (63,786 ) $ 95,793
Common stock issued under employee plans
   1,865 —   —      —   1,865
Shares withheld for net share settlement of RSUs
   (364 ) —   —      —   (364 )
Equity-based compensation expense
   2,186 —   —      —   2,186
Net loss
   —   —   —      (57 ) (57 )
Other comprehensive income
   —   —   78    —   78
Common stock repurchases
   —   (393 ) —      —   (393 )




Balance at September 26, 2020
   $ 192,000 $ (29,551 ) $ 502    $ (63,843 ) $ 99,108

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

~~Accumulated Other Comprehensive Income~~

Condensed Consolidated Statement of Changes in Equity

The changes in ~~accumulated other comprehensive income~~stockholders’ equity by component for the three and ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 and ~~September 26, 2020,~~July 3, 2021, are as ~~follows.~~follows (in thousands):

Three Months Ended

Nine Months Ended



October 2, 2021


Foreign

currency

Unrealized
holding gains
(losses) on
available-for-sale

investments

Total

Foreign
currency

Unrealized
holding gains
(losses) on
available-for-sale

investments

Total



(In thousands)

Beginning balance
   $ 562 $ 9 $ 571 $ 602 $ 38 $ 640
Other comprehensive loss before reclassification
   (7 ) (7 ) (14 ) (47 ) (36 ) (83 )
Amounts reclassified from other comprehensive income (loss)
   —   —   —   —   —   —


Net current-period other comprehensive loss
   (7 ) (7 ) (14 ) (47 ) (36 ) (83 )


Ending balance
   $ 555 $ 2 $ 557 $ 555 $ 2 $ 557


	Three Months Ended July 2, 2022
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Accumulated Deficit			Total Stockholders’ Equity
Balance at April 2, 2022	$	198,960		$	(29,551	)	$	371		$	(43,965	)	$	125,815
Common stock issued under employee plans		1,178			—			—			—			1,178
Shares withheld for net share settlement of RSUs		(160	)		—			—			—			(160	)
Equity-based compensation expense		1,525			—			—			—			1,525
Net loss		—			—			—			(2,818	)		(2,818	)
Other comprehensive loss		—			—			(380	)		—			(380	)

Balance at July 2, 2022	$	201,503		$	(29,551	)	$	(9	)	$	(46,783	)	$	125,160

Three Months Ended

Nine Months Ended



September 26, 2020


Foreign

currency

Unrealized
holding gains
(losses) on
available-for-sale

investments

Total

Foreign
currency

Unrealized
holding gains on
available-for-sale

investments

Total



(In thousands)

Beginning balance
   $ 306    $ 96 $ 402    $ 381    $ 43    $ 424
Other comprehensive income (loss) before reclassification
   124    (24 ) 100    49    29    78
Amounts reclassified from other comprehensive income (loss)
   —      —   —      —      —      —










Net current-period other comprehensive income
   124    (24 ) 100    49    29    78










Ending balance
   $ 430    $ 72 $ 502    $ 430    $ 72    $ 502


	Six Months Ended July 2, 2022
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Accumulated Deficit			Total Stockholders’ Equity
Balance at January 1, 2022	$	199,098		$	(29,551	)	$	578		$	(36,110	)	$	134,015
Common stock issued under employee plans		2,211			—			—			—			2,211
Shares withheld for net share settlement of RSUs		(295	)		—			—			—			(295	)
Equity-based compensation expense		489			—			—			—		��	489
Net loss		—			—			—			(10,673	)		(10,673	)
Other comprehensive loss		—			—			(587	)		—			(587	)

Balance at July 2, 2022	$	201,503		$	(29,551	)	$	(9	)	$	(46,783	)	$	125,160

~~Stock Repurchase Program~~

On November 21, 2013, Intevac’s Board of Directors approved a stock repurchase program authorizing up to $30.0 million in repurchases. On August 15, 2018, Intevac’s Board of Directors approved a $10.0 million increase to the original stock repurchase program for an aggregate authorized amount of up to $40.0 million. At October 2, 2021, $10.4 million remains available for future stock repurchases under the repurchase program.

~~The following table summarizes Intevac’s stock repurchases:~~

Three Months Ended

Nine Months Ended


October 2,

2021

September 26,

2020

October 2,

2021

September 26,

2020



(In thousands, except per share amounts)

Shares of common stock repurchased
   0      0      0      98
Cost of stock repurchased
   $ 0      $ 0      $ 0      $ 393
Average price paid per share
   $ 0      $ 0      $ 0      $ 3.97


	Three Months Ended July 3, 2021
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income		Accumulated Deficit			Total Stockholders’ Equity
Balance at April 3, 2021	$	195,388		$	(29,551	)	$	552	$	(69,234	)	$	97,155
Common stock issued under employee plans		193			—			—		—			193
Shares withheld for net share settlement of RSUs		(512	)		—			—		—			(512	)
Equity-based compensation expense		1,019			—			—		—			1,019
Net loss		—			—			—		(6,126	)		(6,126	)
Other comprehensive income		—			—			19		—			19

Balance at July 3, 2021	$	196,088		$	(29,551	)	$	571	$	(75,360	)	$	91,748


	Six Months Ended July 3, 2021
	Common Stock and Additional Paid-in Capital			Treasury Stock			Accumulated Other Comprehensive Income			Accumulated Deficit			Total Stockholders’ Equity
Balance at January 2, 2021	$	193,197		$	(29,551	)	$	640		$	(62,730	)	$	101,556
Common stock issued under employee plans		1,436			—			—			—			1,436
Shares withheld for net share settlement of RSUs		(532	)		—			—			—			(532	)
Equity-based compensation expense		1,987			—			—			—			1,987
Net loss		—			—			—			(12,630	)		(12,630	)
Other comprehensive loss		—			—			(69	)		—			(69	)

Balance at July 3, 2021	$	196,088		$	(29,551	)	$	571		$	(75,360	)	$	91,748

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Accumulated Other Comprehensive Income (Loss)

~~Intevac records treasury stock purchases under~~

The changes in accumulated other comprehensive income (loss) by component for the ~~cost method using the~~

~~first-in,~~

~~first-out~~

~~(FIFO) method. Upon reissuance of treasury stock, amounts in excess of the acquisition cost~~three and six months ended July 2, 2022 and July 3, 2021, are ~~credited to additional~~

~~paid-in~~as follows.

~~capital. If Intevac reissues treasury stock at an amount below its acquisition cost and additional~~

~~paid-in~~

capital associated with prior treasury stock transactions is insufficient to cover the difference between the acquisition cost and the reissue price, this difference is recorded against the accumulated deficit.

~~10.~~


	Three Months Ended									Six Months Ended

	July 2, 2022
	Foreign currency			Unrealized holding gains (losses) on available-for-sale investments			Total			Foreign currency			Unrealized holding gains (losses) on available-for-sale investments			Total

	(In thousands)
Beginning balance	$	575		$	(204	)	$	371		$	608		$	(30	)	$	578
Other comprehensive loss before reclassification		(219	)		(161	)		(380	)		(252	)		(335	)		(587	)
Amounts reclassified from other comprehensive loss		—			—			—			—			—			—

Net current-period other comprehensive loss		(219	)		(161	)		(380	)		(252	)		(335	)		(587	)

Ending balance	$	356		$	(365	)	$	(9	)	$	356		$	(365	)	$	(9	)


	Three Months Ended							Six Months Ended

	July 3, 2021
	Foreign currency		Unrealized holding gains (losses) on available-for-sale investments			Total		Foreign currency			Unrealized holding gains (losses) on available-for-sale investments			Total

	(In thousands)
Beginning balance	$	534	$	18		$	552	$	602		$	38		$	640
Other comprehensive income (loss) before reclassification		28		(9	)		19		(40	)		(29	)		(69	)
Amounts reclassified from other comprehensive income (loss)		—		—			—		—			—			—

Net current-period other comprehensive income (loss)		28		(9	)		19		(40	)		(29	)		(69	)

Ending balance	$	562	$	9		$	571	$	562		$	9		$	571

11. Net Loss Per Share

The following table sets forth the computation of basic and diluted net loss per ~~share for the three and nine months ended October 2, 2021 and September 26, 2020:~~share:

Three Months Ended

Nine Months Ended


October 2,

2021

September 26,

2020

October 2,

2021

September 26,

2020



(In thousands, except per share amounts)

Net loss
   $ (4,233 )    $ (357 )    $ (16,863 )    $ (57 )








Weighted-average shares – basic
   24,522    23,771    24,265    23,605
Effect of dilutive potential common shares
   0      0      0      0








Weighted-average shares – diluted
   24,522    23,771    24,265    23,605








Net loss per share – basic
   $ (0.17 )    $ (0.02 )    $ (0.69 )    $ (0.00 )








Net loss per share –diluted
   $ (0.17 )    $ (0.02 )    $ (0.69 )    $ (0.00 )

~~As the Company is in a net loss position, all of the Company’s equity instruments are considered antidilutive.~~

~~11.~~

~~Segment Reporting~~

Intevac’s 2 reportable segments are TFE and Photonics. Intevac’s chief operating decision-maker has been identified as the President and CEO, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Segment information is presented based upon Intevac’s management organization structure as of October 2, 2021 and the distinctive nature of each segment. Future changes to this internal financial structure may result in changes to the reportable segments disclosed.

Each reportable segment is separately managed and has separate financial results that are reviewed by Intevac’s chief operating decision-maker. Each reportable segment contains closely related products that are unique to the particular segment. Segment operating profit is determined based upon internal performance measures used by the chief operating decision-maker.

Intevac derives the segment results from its internal management reporting system. The accounting policies Intevac uses to derive reportable segment results are substantially the same as those used for external reporting purposes. Management measures the performance of each reportable segment based upon several metrics, including orders, net revenues and operating income. Management uses these results to evaluate the performance of, and to assign resources to, each of the reportable segments. Intevac manages certain operating expenses separately at the corporate level. Intevac allocates certain of these corporate expenses to the segments in an amount equal to 3% of net revenues. Segment operating income excludes interest income/expense and other financial charges and income taxes according to how a particular reportable segment’s management is measured. Management does not consider impairment charges, gains and losses on divestitures and sales of intellectual property, or unallocated costs in measuring the performance of the reportable segments.

The TFE segment designs, develops and markets vacuum process equipment solutions for high-volume manufacturing of small substrates with precise thin-film properties, such as for the hard drive, solar cell, DCP and advanced semiconductor packaging industries, as well as other adjacent thin-film markets.

~~The Photonics segment develops compact, cost-effective, high-sensitivity digital-optical products for the capture and display of~~

~~low-light~~

~~images. Intevac provides sensors, cameras and systems for government applications such as night vision.~~


	Three Months Ended						Six Months Ended

	July 2, 2022			July 3, 2021			July 2, 2022			July 3, 2021

	(In thousands, except per share amounts)
Net loss from continuing operations	$	(2,580	)	$	(6,124	)	$	(10,300	)	$	(11,692	)
Net loss from discontinued operations, net of taxes	$	(238	)	$	(2	)	$	(373	)	$	(938	)

Net loss	$	(2,818	)	$	(6,126	)	$	(10,673	)	$	(12,630	)
Weighted-average shares – basic		25,141			24,241			24,970			24,137
Effect of dilutive potential common shares		—			—			—			—

Weighted-average shares – diluted		25,141			24,241			24,970			24,137

Basic and diluted net loss per share:
Continuing operations	$	(0.10	)	$	(0.25	)	$	(0.41	)	$	(0.48	)

Discontinued operations	$	(0.01	)	$	(0.00	)	$	(0.01	)	$	(0.04	)

Net loss per share	$	(0.11	)	$	(0.25	)	$	(0.43	)	$	(0.52	)

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

~~Information for each reportable segment for~~

As the ~~three and nine months ended October 2, 2021 and September 26, 2020~~Company is ~~as follows:~~in a net loss position, all of the Company’s equity instruments are considered antidilutive.

~~Net Revenues~~

12. Income Taxes

Three Months Ended

Nine Months Ended



October 2,

2021

September 26,

2020

October 2,

2021

September 26,

2020



(In thousands)

TFE
   $ 7,998    $ 9,367    $ 22,605    $ 33,925
Photonics
   6,795    12,198    22,242    35,323








Total segment net revenues
   $ 14,793    $ 21,565    $ 44,847    $ 69,248

~~Operating Income (Loss)~~

Three Months Ended

Nine Months Ended



October 2,

2021

September 26,

2020

October 2,

2021

September 26,

2020



(In thousands)

TFE
   $ (1,841 ) $ (1,661 ) $ (10,148 ) $ (4,366 )
Photonics
   (341 ) 3,032 (1,742 ) 9,480


Total segment operating income (loss)
   (2,182 ) 1,371 (11,890 ) 5,114


Unallocated costs
   (1,786 ) (1,519 ) (4,891 ) (4,258 )


Income (loss) from operations
   (3,968 ) (148 ) (16,781 ) 856
Interest income and other income (expense), net
   25 8 75 212


Income (loss) before provision for income taxes
   $ (3,943 ) $ (140 ) $ (16,706 ) $ 1,068

~~Total assets for each reportable segment as of October 2, 2021 and January 2, 2021 are as follows:~~

~~Assets~~

October 2,

2021

January 2,

2021



(In thousands)

TFE
   $ 33,411    $ 44,335
Photonics
   16,810    22,923




Total segment assets
   50,221    67,258




Cash, cash equivalents and investments
   50,658    49,568
Restricted cash
   786    787
Deferred income taxes
   5,371    5,335
Other current assets
   907    1,093
Common property, plant and equipment
   1,100    1,443
Common operating lease
right-of-use
assets
   1,267    1,603
Other assets
   183    151




Consolidated total assets
   $ 110,493    $ 127,238

~~Table of Contents~~

~~INTEVAC, INC.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)~~

~~(Unaudited)~~

~~12.~~

~~Income Taxes~~

Intevac recorded income tax provisions of ~~$290,000~~$500,000 and ~~$157,000~~$526,000 for the three and ~~nine~~six months ended ~~October~~July 2, ~~2021,~~2022, respectively, and income tax ~~provisions~~benefits of ~~$217,000~~$165,000 and ~~$1.1 million~~$132,000 for the three and ~~nine~~six months ended ~~September 26, 2020,~~July 3, 2021, respectively. The income tax provisions (benefits) for ~~these~~the three and ~~nine~~six month periods are based upon estimates of annual income (loss), annual permanent differences and statutory tax rates in the various jurisdictions in which Intevac operates. For the three ~~months~~and six month periods ended ~~October~~July 2, ~~2021~~2022 Intevac recorded an income tax ~~provision~~provisions on ~~earnings~~income of its international subsidiaries of ~~$179,000. For the nine months ended October 2, 2021 Intevac~~$390,000 and $364,000, respectively, and recorded ~~an income tax benefit of $29,000 on losses of its international subsidiaries. For the three~~$107,000 and ~~nine months ended October 2, 2021 Intevac recorded $111,000 and $183,000,~~$158,000, respectively, for withholding taxes on royalties paid ~~into~~to the United States from Intevac’s Singapore subsidiary as discrete items. For the three and ~~nine~~six month periods ended ~~September 26, 2020~~July 3, 2021, Intevac recorded income tax ~~provisions~~benefits on ~~earnings~~losses of its international subsidiaries of ~~$111,000~~$189,000 and ~~$659,000,~~$208,000, respectively, and recorded ~~$98,000~~$24,000 and ~~$471,000,~~$72,000, respectively, for withholding taxes on royalties paid ~~into~~to the United States from Intevac’s Singapore subsidiary as discrete items. ~~For all periods presented Intevac utilized net operating loss carry-forwards to offset the impact of global intangible~~

~~low-taxed~~

~~income (“GILTI”).~~ Intevac’s tax rate differs from the applicable statutory rates due primarily to establishment of a valuation allowance, the utilization of deferred and current credits and the effect of permanent differences and adjustments of prior permanent differences. Intevac’s future effective income tax rate depends on various factors, including the level of Intevac’s projected earnings, the geographic composition of worldwide earnings, tax regulations governing each region, net operating loss carry-forwards, availability of tax credits and the effectiveness of Intevac’s tax planning strategies. Management carefully monitors these factors and timely adjusts the effective income tax rate.

The Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) was enacted on March 27, 2020 in the United States. The CARES Act includes several significant provisions for corporations, including the usage of net operating losses and payroll benefits. Several foreign

(non-U.S.)

jurisdictions in which we operate have taken similar economic stimulus measures. The Company evaluated the provisions of the CARES Act and other

non-U.S.

economic measures and determined the impact on our financial position at ~~October~~July 2, ~~2021~~2022 and on the results of operations and cash flows for the three and ~~nine~~six months then ended to be as follows.

Under the CARES Act, we elected to defer payment, on an interest-free basis, of the employer portion of social security payroll taxes incurred from March 27, 2020 to December 31, 2020.

One-half

of such deferral amount became due on December 31, 2021.

One-half

of such deferral amount will become due on ~~each of December 31, 2021 and~~ December 31, 2022. We elected to utilize this deferral program to delay payment of $764,000 of the employer portion of payroll taxes which were incurred between March 27, 2020 and December 31, 2020. On the condensed consolidated balance sheets, the ~~short-term portion of the~~ deferred payroll tax liability in the amount of $407,000 as of July 2, 2022 is included in accrued payroll and related ~~liabilities, while the long-term portion is included in other long-term~~ liabilities. The Company also utilized the employee retention tax credit under the CARES Act for certain qualifying employee salary and wage expenditures. Tax benefits under the employee retention tax credit ~~were~~are not significant.

In Singapore, Intevac ~~receives~~received government assistance under the Job Support Scheme (“JSS”). The purpose of the JSS is to provide wage support to employers to help them retain their local employees. During the ~~nine months ended October 2,~~first half of fiscal 2021, the Company received ~~$83,000~~$82,000 in JSS grants, of which ~~$56,000~~$55,000 is reported as a reduction of cost of net revenues, $10,000 is reported as a reduction of research and development ~~(“R&D”)~~ expenses and $17,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated ~~statements~~statement of operations. The Company did not receive any JSS grants in the first half of fiscal 2022.

13. Restructuring and Other Costs, Net

During the first quarter ~~ended September 26, 2020,~~of fiscal 2022, Intevac substantially completed implementation of the ~~Company received $124,000~~2022 cost reduction plan (the “2022 Cost Reduction Plan”), which was intended to reduce our overall cost structure and optimize our operational design, inclusive of the stranded overhead associated with the divestiture of the Photonics business. The restructuring program includes management reorganization and the right sizing of certain technology development, marketing and administrative functions. We incurred restructuring costs of $1.2 million in ~~JSS grants,~~estimated severance and the related modification of ~~which $72,000 is~~certain stock-based awards. Other costs incurred as part of the 2022 Cost Reduction Plan include: (i) a benefit of $1.3 million related to the stock-based compensation forfeitures related to the employees affected by the reduction in workforce, (ii) $1.5 million for fixed asset disposals and (iii) $755,000 for write-offs of excess inventory. The 2022 Cost

Table of Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

Reduction Plan reduced the workforce by 6 percent. The cost of implementing the 2022 Cost Reduction Plan was reported ~~as a reduction of~~under cost of net revenues ~~$20,000 is reported as a reduction of R&D~~and operating expenses ~~and $32,000 is reported as a reduction of selling, general and administrative expenses on~~in the condensed consolidated ~~statement~~statements of operations. Implementation of the 2022 Cost Reduction Plan is expected to reduce salary, wages and other employee-related expenses by approximately $2.1 million on an annual basis.

The changes in restructuring reserves, which resulted from cash-based severance payments and other employee-related costs, associated with the 2022 Cost Reduction Plan for the three and six months ended July 2, 2022 were as follows.


	Employee Termination Costs
	(In thousands)
Balance at January 1, 2022	$	—
Provision for restructuring charges under the 2022 Cost Reduction Plan		1,232
Cash payments made		(757	)
Non-cash utilization (a)		37

Balance at April 2, 2022		512
Cash payments made		(179	)

Balance at July 2, 2022 (b)	$	333

(a)	Acceleration of equity awards.

(b)	Liability for employee termination costs is included in accrued payroll and related liabilities.

During the ~~nine~~fourth quarter of fiscal 2021, the Company recorded asset impairment and restructuring charges associated with the sale of the Photonics division including (i) $693,000 in severance and other employee-related costs related to the termination of the Photonics general manager; (ii) $1.2 million in asset impairment charges on the Company’s ROU asset and (iii) $665,000 in accruals for common area charges associated with an unused space commitment to EOTECH. In consideration of EOTECH’s assumption of certain lease obligations related to the Company’s Santa Clara, California campus, which assumed lease obligations pertain in part to excess space beyond that required by EOTECH’s currently anticipated operation of the Photonics division, the Company agreed to pay EOTECH the amount of $2.1 million, which is payable in (i) one initial installment of $308,000 on January 10, 2022 and (ii) 7 equal quarterly installments of $259,000. The Company recorded an asset impairment charge against its ROU asset in the amount of $1.2 million associated with the excess space noted above. The Company recorded a liability to EOTECH in the amount of $665,000, the amount related to common area charges which are not included in the base rental payments or the lease liability on the Company’s condensed consolidated balance sheet. During the first quarter of fiscal 2022, the Company recorded restructuring charges associated with the sale of the Photonics division including $37,000 in severance and other employee-related costs related to the termination of four Photonics employees and $75,000 in stock-based compensation associated with the modification of certain stock-based awards for eighty Photonics employees.

The changes in restructuring reserves, which resulted from cash-based severance payments and other employee-related costs and other exit costs associated with the Photonics divestiture for the three and six months ended ~~September 26, 2020, the Company received $434,000 in JSS grants,~~July 2, 2022 were as follows.


	Employee Termination Costs			Other Exit Costs			Total

	(In thousands)
Balance at January 1, 2022	$	358		$	665		$	1,023
Provision for restructuring charges associated with Photonics divestiture (a)		112			2			114
Cash payments made		(137	)		(128	)		(265	)
Non-cash utilization (b)		(75	)		—			(75	)

Balance at April 2, 2022	$	258		$	539		$	797

Provision for restructuring charges associated with Photonics divestiture (a)		—			4			4
Cash payments made		(90	)		(77	)		(167	)

Balance at July 2, 2022	$	168	(c)	$	466		$	634

Table of which $252,000 is reported as a reduction of cost of net revenues, $68,000 is reported as a reduction of R&D expenses and $114,000 is reported as a reduction of selling, general and administrative expenses on the condensed consolidated statement of operations.Contents

INTEVAC, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)

(Unaudited)

~~13.~~

(a)

~~Restructuring Charges~~

Included in loss from discontinued operations (See Note 2).

(b)	Acceleration of equity awards.

(c)	Liability for employee termination costs is included in accrued payroll and related liabilities.

During the third quarter of fiscal 2021, Intevac substantially completed implementation of the 2021 cost reduction plan (the “2021 Cost Reduction Plan”), which was intended to reduce expenses and reduce its workforce by 5.2 percent. The cost of implementing the 2021 Cost Reduction Plan was reported under cost of net revenues and operating expenses in the condensed consolidated statements of operations. Substantially all cash outlays in connection with the 2021 Cost Reduction Plan occurred in the first nine months of fiscal 2021. Implementation of the 2021 Cost Reduction Plan is expected to reduce salary, wages and other employee-related expenses by approximately $2.0 million on an annual basis.

~~Table of Contents~~

~~INTEVAC, INC.~~

~~NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS – (Continued)~~

~~(Unaudited)~~

During the third quarter of fiscal 2020, Intevac substantially completed implementation of the 2020 cost reduction plan (the “2020 Cost Reduction Plan”), which was intended to reduce expenses and reduce its workforce by 1.0 percent. The cost of implementing the 2020 Cost Reduction Plan was reported under cost of net revenues and operating expenses in the condensed consolidated statements of operations. Substantially all cash outlays in connection with the 2020 Cost Reduction Plan occurred in the third quarter of fiscal 2020. Implementation of the 2020 Cost Reduction Plan is expected to reduce salary, wages and other employee-related expenses by approximately $864,000 on an annual basis.

The changes in restructuring reserves, which resulted from cash-based severance payments and other employee-related costs, associated with the ~~cost reduction plans~~2021 Cost Reduction Plan for the ~~three and nine~~six months ended ~~October 2,~~July 3, 2021 ~~and September 26, 2020~~ were as follows.

Three
Months
Ended

October 2,

2021

Nine
Months
Ended

October 2,

2021

Three and
Nine

Months
Ended
September

26, 2020



(In thousands)


Severance and other employee-related costs

Beginning balance
   $ —   $ —   $ —
Provision for restructuring reserves
   276 319 103
Cash payments made
   (276 ) (319 ) (103 )


Ending balance
   $ —   $ —   $ —


	~~14.~~Six Months Ended July 3, 2021
	(In thousands)
Beginning balance	$	—
Provision for restructuring reserves		43
Cash payments made		(43	)
		~~Contingencies~~
Ending balance	$	—

14. Commitments and Contingencies

From time to time, Intevac may have certain contingent liabilities that arise in the ordinary course of its business activities. Intevac accounts for contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated.

Legal Matters

From time to time, Intevac receives notification from third parties, including customers and suppliers, seeking indemnification, litigation support, payment of money or other actions in connection with claims made against them. In addition, from time to time, Intevac receives notification from third parties claiming that Intevac may be or is infringing their intellectual property or other rights. Intevac also is subject to various other legal proceedings and claims, both asserted and unasserted, that arise in the ordinary course of business. Although the outcome of these claims and proceedings cannot be predicted with certainty, Intevac does not believe that any existing proceedings or claims will have a material adverse effect on its consolidated financial condition or results of operations.

In July 2020, Robin Quiusky, a former contract employee who worked for us via a staffing agency, filed an action against us under the Private Attorneys General Act (“PAGA”) in California state court (Quiusky v. Intevac, Inc., et al) alleging that the Company failed to provide rest and meal breaks, pay overtime and reimburse business expenses for

non-exempt

California employees. The former employee ~~has since~~subsequently added class action claims to his original complaint. The ~~Company disputes~~parties participated in a confidential mediation on February 1, 2022, and reached a settlement resolving the case. We are awaiting approval of the settlement by the court. Payment on the claims is expected to be made in the second half of 2022. The settlement effectively extinguishes the Quiusky v. Intevac, Inc., et al lawsuit. The settlement includes the dismissal of all claims against the Company and ~~intends~~related parties in the Quiusky lawsuit and claim under the PAGA, without any admission of liability or wrongdoing attributed to ~~defend~~ the ~~matter vigorously. Given~~Company. Because of the uncertainty ofsurrounding this litigation, ~~and the preliminary stage of the case,~~no litigation reserve had been previously established by the Company ~~is currently unable to estimate~~resulting in the ~~amount~~full $1.0 million settlement expense being recognized in the fourth quarter of ~~loss, or range of possible loss, that may result from this action. Accordingly, no accrual has been made with respect to this matter.~~

fiscal 2021.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

This Quarterly Report on Form

10-Q

contains forward-looking statements, which involve risks and uncertainties. Words such as “believes,” “expects,” “anticipates” and the like indicate forward-looking statements. These forward-looking statements include comments related to Intevac’s shipments, projected revenue recognition, product costs, gross margin, operating expenses, interest income, income taxes, cash balances and financial results in ~~2021~~2022 and beyond; projected customer requirements for Intevac’s new and existing products, and when, and if, Intevac’s customers will place orders for these products; ~~Intevac’s ability to proliferate its Photonics technology into major military programs;~~ the timing of delivery and/or acceptance of the systems and products that comprise Intevac’s backlog for revenue and the Company’s ability to achieve cost savings. Intevac’s actual results may differ materially from the results discussed in the forward-looking statements for a variety of reasons, including those set forth under “Risk Factors” and in other documents we file from time to time with the Securities and Exchange Commission, ~~(“SEC”),~~ including our Annual Report on Form

10-K

filed on February 17, ~~2021, and~~2022, our Quarterly Reports on Form

10-Q

and our Current Reports on Form

8-K.

Intevac’s trademarks include the following: “200 Lean

~~,” “DiamondClad~~

~~,” “EBAPS~~

~~,” “ENERG~~

~~,” “LIVAR~~

,” “INTEVAC LSMA

,” “INTEVAC MATRIX

,” ~~“MicroVista~~

~~,” “NightVista~~

,” “oDLC

~~,” “INTEVAC VERTEX~~

~~,” “VERTEX Marathon~~

,” and ~~“VERTEX SPECTRA~~“TRIO

®™

.”

Discontinued Operations

~~Table~~On December 30, 2021, the Company completed the sale of ~~Contents~~its Photonics business to EOTECH, LLC, a Michigan limited liability company (“EOTECH”). As a result of the disposition, the results of operations from the Photonics reporting segment are reported as “Net loss from discontinued operations, net of taxes” in the condensed consolidated financial statements. The Company has recast prior period amounts presented to provide visibility and comparability. All discussion herein, unless otherwise noted, refers to Intevac’s remaining operating segment after the disposition, the Thin Film Equipment (“TFE”) business. See Note 2 “Divestiture and Discontinued Operations” to the condensed consolidated financial statements in Item 1 of this Quarterly Report on Form

10-Q.

Overview

Intevac is a provider of vacuum deposition equipment for a wide variety of thin-film ~~applications, and a leading provider of digital night-vision technologies and products to the defense industry.~~applications. The Company leverages its core capabilities in high-volume manufacturing of small substrates to provide process manufacturing equipment solutions to the hard disk drive (“HDD”), and display cover panel (“DCP”)~~, photovoltaic (“PV”) solar cell, and advanced semiconductor packaging~~ industries. ~~Intevac also provides sensors, cameras and systems for government applications such as night vision.~~ Intevac’s customers include manufacturers of hard disk media ~~DCPs~~ and ~~solar cells, semiconductor outsourced assembly and test companies as well as the U.S. government and its agencies, allies and contractors.~~DCPs. Intevac ~~reports two segments: Thin-film Equipment (“TFE”) and Photonics.~~

operates in a single segment: TFE. Product development and manufacturing activities occur in North America and Asia. Intevac also has field offices in Asia to support its ~~TFE~~ customers. Intevac’s products are highly technical and are sold primarily through Intevac’s direct sales force. ~~Intevac also sells its products through distributors in Japan and China.~~

Intevac’s results of operations are driven by a number of factors including success in its equipment growth initiatives in the DCP ~~solar and advanced semiconductor packaging markets~~market and by worldwide demand for HDDs. Demand for HDDs depends on the growth in digital data creation and storage, the rate of areal density improvements, and the

end-user

demand for PCs, enterprise data storage, nearline “cloud” applications, video players and video game consoles that include such drives. Intevac continues to execute its strategy of ~~equipment~~ diversification ~~into new markets~~beyond the HDD industry by ~~introducing new products, such as~~focusing on the Company’s ability to provide proprietary tools to enhance scratch protection and durability for ~~a thin-film physical vapor deposition (“PVD”) application for protective coating for~~the DCP market and by working to develop the next generation of high volume DCP manufacturing ~~a thin-film PVD application for PV solar cell manufacturing, and a PVD~~

~~fan-out~~

~~application for advanced semiconductor packaging.~~equipment. Intevac believes that ~~expansion into these markets~~its renewed focus on the DCP market will result in incremental equipment revenues for Intevac and decrease Intevac’s dependence on the HDD industry. Intevac’s equipment business is subject to cyclical industry conditions, as demand for manufacturing equipment and services can change depending on supply and demand for HDDs and cell phones ~~PV cells, and semiconductor chips~~ as well as other factors such as global economic conditions and technological advances in fabrication processes.

In March 2022, the Company’s management approved a restructuring plan to realign the Company’s operational focus, scale the business and improve costs. The restructuring program includes (i) reducing the Company’s headcount and (ii) eliminating several research and development (“R&D”) programs and product offerings. As part of this realignment effort, the Company will no longer be pursuing several DCP projects including the coating of the backside covers of smartphones, solar ion implantation (also known as ENERGi

), and advanced packaging for semiconductor manufacturing.

Table of Contents

The following table presents certain significant measurements for the three and ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 and ~~September 26, 2020:~~July 3, 2021:


	Three months ended									Nine months ended

	October 2, 2021			September 26, 2020			Change over prior period			October 2, 2021			September 26, 2020				Change over prior period			Three months ended									Six months ended
																				July 2, 2022			July 3, 2021			Change over prior period			July 2, 2022			July 3, 2021			Change over prior period
	(In thousands, except percentages and per share amounts)
																				(In thousands, except percentages and per share amounts)
Net revenues	$	14,793		$	21,565		$	(6,772	)	$	44,847		$	69,248			$	(24,401	)	$	9,307		$	5,369		$	3,938		$	13,752		$	14,607		$	(855	)
Gross profit	$	5,527		$	9,300		$	(3,773	)	$	11,689		$	28,876			$	(17,187	)	$	4,487		$	1,006		$	3,481		$	5,209		$	3,140		$	2,069
Gross margin percent		37.4	%		43.1	%		(5.7) points			26.1	%		41.7	%			(15.6)points			48.2	%		18.7	%		29 points			37.9	%		21.5	%		16 points
Income (loss) from operations	$	(3,968	)	$	(148	)	$	(3,820	)	$	(16,781	)	$	856			$	(17,637	)
Loss from operations																				$	(2,397	)	$	(6,309	)	$	3,912		$	(10,084	)	$	(11,874	)	$	1,790
Loss from continuing operations																				$	(2,580	)	$	(6,124	)	$	3,544		$	(10,300	)	$	(11,692	)	$	1,392
Loss from discontinued operations																				$	(238	)	$	(2	)	$	(236	)	$	(373	)	$	(938	)	$	565
Net loss	$	(4,233	)	$	(357	)	$	(3,876	)	$	(16,863	)	$	(57	)	��	$	(16,806	)	$	(2,818	)	$	(6,126	)	$	3,308		$	(10,673	)	$	(12,630	)	$	1,957
Net loss per diluted share	$	(0.17	)	$	(0.02	)	$	(0.15	)	$	(0.69	)	$	(0.00	)		$	(0.69	)	$	(0.11	)	$	(0.25	)	$	0.14		$	(0.43	)	$	(0.52	)	$	0.09

Net revenues increased during the second quarter of fiscal 2022 compared to the same period in the prior year primarily due to higher equipment sales to HDD manufacturers. Higher gross margin in the second quarter of fiscal 2022 reflected the higher-margin contribution from HDD upgrades. Fees earned pursuant to the TSA with EOTECH since the divestiture of Photonics (“TSA fees”) were $408,000 for the ~~third~~three months ended July 2, 2022, of which $14,000 was reported as a reduction of cost of net revenues and $394,000 was reported as a reduction of selling, general and administrative expenses. The agreed-upon charges for such services are generally intended to allow the service provider to recover all costs and expenses of providing such services. The Company reported a smaller net loss for the second quarter of fiscal 2022 compared to the second quarter of fiscal 2021 due to higher revenues, higher gross margins and lower operating costs as a result of the cost reduction actions taken in the first quarter of fiscal 2022.

Net revenues decreased during the first half of fiscal 2022 compared to the same period in the prior year primarily due to lower ~~equipment sales to HDD manufacturers, lower Photonics product sales and lower Photonics contract R&D. TFE~~system sales. We did not recognize revenue on any ~~systems~~system sales in ~~either~~ the ~~third quarter~~first half of fiscal 2022 compared to one MATRIX PVD system for advanced semiconductor packaging recognized in the first half of fiscal 2021. Higher gross margin in the first half of fiscal 2022 reflects the higher-margin contribution from HDD upgrades, offset in part by $755,000 in charges for excess and obsolete inventory as part of the Company’s realignment effort. Lower gross margin in the first half of fiscal 2021 orreflected the ~~third quarter~~lower-margin contribution from the first MATRIX PVD system for advanced semiconductor packaging. In March 2022, the Company’s management approved a restructuring plan to realign the Company’s operational focus, scale the business and improve costs. R&D expenses for the first half of fiscal ~~2020.~~2022 include $1.5 million in expenditures related to the disposal of certain lab equipment as part of the realignment effort. The cost of employee severance associated with the realignment effort of $1.2 million was offset in full by stock-based compensation forfeitures related to the employees affected by the reduction in workforce. TSA fees were $1.2 million for the six months ended July 2, 2022, of which $23,000 was reported as a reduction of cost of net revenues and $1.2 million was reported as a reduction of selling, general and administrative expenses. During the ~~third quarter~~first half of fiscal 2021, the Company ~~did not receive any significant government assistance related to~~

~~COVID-19~~

~~from the government of Singapore. During the third quarter of fiscal 2020, the Company~~ received ~~$124,000~~$82,000 in government assistance related to

COVID-19

from the government of Singapore, of which $72,000 was reported as a reduction of cost of net revenues, $20,000 was reported as a reduction of R&D expenses and $32,000 was reported as a reduction of selling, general and administrative expenses. The Company reported a larger net loss for the third quarter of fiscal 2021 compared to the third quarter of fiscal 2020 due to lower revenues, lower gross profit and higher R&D expenses, offset in part by lower selling, general and administrative expenses.

Net revenues for the first nine months of fiscal 2021 decreased compared to the same period in the prior year primarily due to lower equipment sales to HDD manufacturers, lower Photonics product sales and lower Photonics contract R&D revenue, offset in part by higher equipment sales for advanced semiconductor packaging. TFE recognized revenue on one MATRIX PVD system for advanced semiconductor packaging in the first nine months of fiscal 2021 compared to two 200 Lean

HDD systems in the first nine months of fiscal 2020. During the first nine months of fiscal 2021, Photonics delivered the first prototype units for our U.S. Army Integrated Visual Augmentation System (“IVAS”) product. During the first nine months of fiscal 2021, the Company received $83,000 in government assistance related to

~~COVID-19~~

~~from the government of Singapore of which $56,000~~$55,000 was reported as a reduction of cost of net revenues, $10,000 was reported as a reduction of R&D expenses and $17,000 was reported as a reduction of selling, general and administrative expenses. ~~During~~The Company did not receive any JSS grants in the ~~nine months~~first half of fiscal ~~2020, the Company received $434,000 in government assistance related to~~

~~COVID-19~~

from the government of Singapore of which $252,000 was reported as a reduction of cost of net revenues, $68,000 was reported as a reduction of R&D expenses and $114,000 was reported as a reduction of selling, general and administrative expenses.2022. The Company reported a ~~larger~~smaller net loss for the first ~~nine months~~half of fiscal ~~2021~~2022 compared to the first ~~nine months~~half of fiscal ~~2020~~2021 due to ~~lower revenues, lower~~higher gross ~~profit and higher spending on R&D,~~margins, offset in part by lower ~~selling, general~~revenues and ~~administrative expenses.~~

~~Table~~higher operating costs as a result of ~~Contents~~the realignment effort.

We believe fiscal ~~2021~~2022 will be a challenging year, and ~~we do~~Intevac does not expect to be profitable in fiscal ~~2021. We expect~~2022. Intevac expects that ~~fiscal 2021~~2022 HDD equipment sales will be ~~lower than fiscal 2020 levels. In~~similar to 2021 levels as we expect ~~product revenue~~a customer to take delivery of one system in ~~Photonics~~backlog. We believe there will be improvements to ~~decline as shipments for the Apache camera under the current contract with the U.S. government concluded~~our HDD equipment sales in the ~~third quarter of~~future as we expect a customer to start taking deliveries from the remaining ten systems in backlog starting in fiscal ~~2020. We were recently awarded~~2023. However, our operating results and growth prospects could be impacted by macroeconomic conditions such as a

~~5-year,~~

~~$16.3 million IDIQ (indefinite delivery/indefinite quantity) contract~~ global economic slowdown, global economic instability and political conflicts, wars, and public health crises. In addition, rising inflation and interest rates may impact demand for ~~the Apache helicopter program~~our products and received our first order under this contract in the third quarter of fiscal 2021. In the remainder of fiscal 2021, we will continue to deliver product shipments of the night-vision camera modules for the F35 Joint Strike Fighter programservices and our ~~LIVAR cameras for advanced precision targeting systems. In fiscal 2021, we expect decreased contract R&D revenue as development work on the multi-year IVAS contract award for the development~~cost to provide products and production of digital night-vision cameras to support the U.S. Army’s IVAS program completed in early 2021. In fiscal 2021, we delivered the first prototype units for our IVAS product. We do not expect to receive any follow on production orders for our IVAS product for the remainder of fiscal 2021 as the deployment of which was recently delayed for approximately one year while the platform is further developed and enhanced. We do not expect to receive any additional government assistance related toservices.

COVID-19

~~from the government of Singapore in the remainder of fiscal 2021.~~

~~Updates to the~~

~~COVID-19~~

~~response included in our Annual Report on Form~~

~~10-K~~

~~for the fiscal year ended January 2, 2021~~Update

The impact of

COVID-19,

including changes in consumer behavior, pandemic fears, and market downturns, as well as restrictions on business and individual activities, has created significant volatility in the global economy and led to reduced economic activity. Although

COVID-19

vaccines are now broadly distributed and administered, there remains significant uncertainty concerning the magnitude of the impact and the duration of the

COVID-19

pandemic. IfAs new strains of

COVID-19

develop, the continued impacts to our business could be material to our fiscal ~~2021~~2022 results. Further, the impacts of inflation and interest rate fluctuations on our business

Table of Contents

and the broader economy, which may continue to be exacerbated by the economic recovery from the

COVID-19

pandemic, may also impact our financial condition and results of operations. Our customers may delay or cancel orders due to reduced demand, supply chain disruptions, and/or travel restrictions and border closures. We have experienced pandemic-related delays in our ~~TFE~~ evaluation and development work. In response to

to COVID-19,

we implemented initiatives to safeguard our employees, including work-from-home protocols. ~~In June 2021~~Although we ~~began reopening~~have since fully reopened our offices ~~on a regional basis~~ in accordance with local ~~authority~~ guidelines, ~~while ensuring that~~ our return to work is thoughtful, prudent, and handled with a safety-first approach. All employees in the United States who could work from home did so through the middle of June 2021 when we fully reopened our offices as restrictions were lifted by the applicable authorities. All employees in Singapore that can do so continue to work remotely and will do so until restrictions are lifted by the applicable authorities in Singapore. Our employees’ health and safety isremain our top priority, and we will continue to monitor local restrictions across the world, the administration and efficacy of vaccines and the number of new ~~cases.~~cases, to determine whether and when additional safeguards may become necessary.

In Singapore, Intevac ~~receives~~received government assistance under the Job Support Scheme (“JSS”). The purpose of the JSS is to provide wage support to employers to help them retain their local employees. Under the JSS, Intevac received ~~$83,000~~$82,000 in JSS grants in the first ~~nine months~~half of fiscal 2021. ~~During the three and nine months ended September 26, 2020, the~~The Company ~~received $124,000 and $434,000, respectively, in JSS grants. Intevac does~~did not ~~expect to~~ receive any ~~additional government assistance related to~~

~~COVID-19~~

~~from the government of Singapore~~JSS grants in the ~~remainder~~first half of fiscal ~~2021.~~2022.

For the three and ~~nine~~six months ended ~~October~~July 2, ~~2021,~~2022, the Company’s expenses included approximately ~~$36,000~~$16,000 and ~~$123,000,~~$34,000, respectively, due to costs related to actions taken in response to

COVID-19.

For the three and ~~nine~~six months ended ~~September 26, 2020,~~July 3, 2021, the Company’s expenses included approximately ~~$43,000~~$44,000 and ~~$116,000,~~$87,000, respectively, due to costs related to actions taken in response to

COVID-19.

Results of Operations

Net revenues

Three months ended

Nine months ended



October 2,
2021

September 26,
2020

Change over

prior period

October 2,
2021

September 26,
2020

Change over

prior period



(In thousands)

TFE
   $ 7,998    $ 9,367    $ (1,369 ) $ 22,605    $ 33,925    $ (11,320 )
Photonics:

Contract R&D
   3,093    6,538    (3,445 ) 9,437    17,659    (8,222 )
Products
   3,702    5,660    (1,958 ) 12,805    17,664    (4,859 )










   6,795    12,198    (5,403 ) 22,242    35,323    (13,081 )










Total net revenues
   $ 14,793    $ 21,565    $ (6,772 ) $ 44,847    $ 69,248    $ (24,401 )


	Three months ended						Six months ended
	July 2, 2022		July 3, 2021		Change over prior period		July 2, 2022		July 3, 2021		Change over prior period

	(In thousands)
Net revenues	$	9,307	$	5,369	$	3,938	$	13,752	$	14,607	$	(855	)

~~Table of Contents~~

~~TFE revenue~~Revenue for the three months ended ~~October~~July 2, ~~2021 decreased~~2022 increased compared to the same period in the prior year as a result of ~~lower~~higher sales of technology upgrades, ~~spares~~spare parts and service. ~~TFE revenue~~Revenue for the ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 decreased compared to the same period in the prior year as a result of lower sales of systems, spare parts and ~~technology upgrades,~~service, offset in part by higher sales ~~of spares and service. TFE revenue~~technology upgrades. Revenue for ~~both~~ the three months ended ~~October~~July 2, ~~2021~~2022 and ~~September 26, 2020~~July 3, 2021 did not include revenue recognized for any systems. ~~TFE~~Revenue for the six months ended July 2, 2022 did not include revenue recognized for any systems compared to revenue ~~in the first nine months of fiscal 2021~~recognized on one MATRIX PVD system for advanced semiconductor packaging ~~compared to revenue recognized for two 200 Lean~~

~~HDD systems~~ in the first ~~nine months~~half of fiscal ~~2020.~~

Photonics revenue for the three and nine months ended October 2, 2021 decreased compared to the same periods in the prior year as a result of lower product sales revenues and lower contract R&D work. Development work on the multi-year IVAS contract award for the development and production of digital night-vision cameras to support the U.S. Army’s IVAS program completed in early 2021. ~~During the first nine months of fiscal 2021, Photonics delivered the first prototype units for our IVAS product.~~

Backlog

October 2,

2021

January 2,

2021

September 26,

2020



(In thousands)

TFE
   $ 16,925    $ 5,623    $ 18,092
Photonics
   27,942    41,317    45,159






Total backlog
   $ 44,867    $ 46,940    $ 63,251


	July 2, 2022		January 1, 2022		July 3, 2021

	(In thousands)
Backlog	$	100,194	$	24,725	$	18,943

~~TFE backlog~~Backlog at ~~October~~July 2, ~~2021,~~2022 included eleven 200 Lean HDD systems. Backlog at January 2,1, 2022 included one 200 Lean HDD system. Backlog at July 3, 2021 ~~and at September 26, 2020~~ did not include any 200 Lean HDD systems.

Revenue by geographic region


	Three Months Ended						Three Months Ended

	October 2, 2021						September 26, 2020
													Three Months Ended				Six Months Ended
	(In thousands)												July 2, 2022		July 3, 2021		July 2, 2022		July 3, 2021
	TFE		Photonics		Total		TFE		Photonics		Total
													(In thousands)
United States	$	220	$	6,738	$	6,958	$	1,764	$	12,079	$	13,843	$	1,656	$	2,121	$	1,950	$	2,488
Asia		7,778		—		7,778		7,536		—		7,536		7,651		3,248		11,802		8,269
Europe		—		57		57		67		119		186		—		—		—		3,850

Total net revenues	$	7,998	$	6,795	$	14,793	$	9,367	$	12,198	$	21,565	$	9,307	$	5,369	$	13,752	$	14,607

Nine Months Ended

Nine Months Ended



October 2, 2021

September 26, 2020



(In thousands)


TFE

Photonics

Total

TFE

Photonics

Total


United States
   $ 2,708    $ 22,069    $ 24,777    $ 2,596    $ 35,060    $ 37,656
Asia
   16,047    —      16,047    31,262    —      31,262
Europe
   3,850    173    4,023    67    263    330












Total net revenues
   $ 22,605    $ 22,242    $ 44,847    $ 33,925    $ 35,323    $ 69,248

International sales include products shipped to overseas operations of U.S. companies. The decrease in sales to the U.S. region in the three and ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 versus the ~~same periods~~three and six months ended July 3, 2021, reflected lower HDD upgrade sales, offset in part by higher spare parts and service sales. The increase in sales to the Asia region in the ~~prior year,~~three and six months ended July 2, 2022 versus the three and six months ended July 3, 2021, reflected ~~lower Photonics product shipments~~higher HDD upgrade, spare parts and ~~lower Photonics contract R&D work.~~service sales. Sales to the Asia region in ~~both three and nine month~~all periods ~~ended October 2, 2021~~presented did not include any systems. Sales to the ~~Asia region in the nine months ended September 26, 2020 included two 200 Lean~~

~~HDD systems. Sales to the~~ Europe region in the ~~nine~~six months ended ~~October 2,~~July 3, 2021 included one MATRIX PVD system for advanced semiconductor packaging. ~~Sales to the Europe region in the three and nine months ended September 26, 2020 were not significant.~~

Table of Contents

Gross profit

Three months ended

Nine months ended



October 2,

2021

September 26,

2020

Change over

prior period

October 2,

2021

September 26,

2020

Change over

prior period



(In thousands, except percentages)

TFE gross profit
   $ 3,350 $ 4,075 $ (725 ) $ 6,491 $ 13,622 $ (7,131 )
% of TFE net revenues
   41.9 % 43.5 % 28.7 % 40.2 %
Photonics gross profit
   $ 2,177 $ 5,225 $ (3,048 ) $ 5,198 $ 15,254 $ (10,056 )
% of Photonics net revenues
   32.0 % 42.8 % 23.4 % 43.2 %
Total gross profit
   $ 5,527 $ 9,300 $ (3,773 ) $ 11,689 $ 28,876 $ (17,187 )
% of net revenues
   37.4 % 43.1 % 26.1 % 41.7 %


	Three months ended								Six months ended
	July 2, 2022			July 3, 2021			Change over prior period		July 2, 2022			July 3, 2021			Change over prior period

	(In thousands, except percentages)
Gross profit	$	4,487		$	1,006		$	3,481	$	5,209		$	3,140		$	2,069
% of net revenues		48.2	%		18.7	%				37.9	%		21.5	%

Cost of net revenues consists primarily of purchased materials, ~~and costs attributable to contract research and development,~~ and also includes fabrication, assembly, test and installation labor and overhead, customer-specific engineering costs, warranty costs, royalties, provisions for inventory reserves and scrap.

~~TFE gross~~Gross margin was ~~41.9%~~48.2% in the three months ended ~~October~~July 2, ~~2021~~2022 compared to ~~43.5%~~18.7% in the three months ended ~~September 26, 2020~~July 3, 2021 and was ~~28.7%~~37.9% in the ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 compared to ~~40.2%~~21.5% in the ~~nine~~six months ended ~~September 26, 2020.~~July 3, 2021. The ~~decline~~improvement in the gross margin percentage for the three months ended ~~October~~July 2, ~~2021~~2022 compared to the same period in the prior year was due primarily to ~~lower~~higher revenues, the higher-margin contribution from HDD upgrades, and ~~lower~~higher factory ~~utilization, offset in part by favorable product mix.~~utilization. The ~~decrease~~improvement in the gross margin percentage for the ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 was due primarily to ~~lower revenues, lower factory utilization,~~the higher-margin contribution from HDD upgrades, offset in part by $755,000 in charges for excess and obsolete inventory as part of the Company’s realignment effort. Gross margin for the six months ended July 3, 2021 reflects the lower margin on the first MATRIX PVD system for advanced semiconductor packaging. Gross margins ~~in the TFE business~~ will vary depending on a number of factors, including revenue levels, product mix, product cost, system configuration and pricing, factory utilization, and provisions for excess and obsolete inventory.

~~Photonics gross margin was 32.0% in~~

Research and development expense


	Three months ended							Six months ended
	July 2, 2022		July 3, 2021		Change over prior period			July 2, 2022		July 3, 2021		Change over prior period
1
	(In thousands)
Research and development expense	$	2,868	$	3,118	$	(250	)	$	7,028	$	6,483	$	545

Research and development spending during the three months ended ~~October~~July 2, 2021 compared to 42.8% in the three months ended September 26, 2020 and was 23.4% in the nine months ended October 2, 2021 compared to 43.2% in the nine months ended September 26, 2020. The decline in gross margin for the three months October 2, 2021 was due to lower revenue levels and lower margins on contract R&D work. The decline in gross margin for the nine months ended October 2, 2021 was due to lower revenue levels, incremental

~~start-up~~

~~costs for~~

~~non-recurring~~

engineering associated with the first shipments of our IVAS product, lower margins on contract R&D work primarily due to additional development costs to integrate our camera into the IVAS platform, incremental scrapping of materials and loss provisions taken on several small firm fixed price contracts. Gross margins in the Photonics business will vary depending on a number of factors, including sensor yield, product mix, product cost, pricing, factory utilization, provisions for warranty and inventory reserves.

~~Research and development~~

Three months ended

Nine months ended



October 2,

2021

September 26,

2020

Change over

prior period

October 2,

2021

September 26,

2020

Change over

prior period



(In thousands)

Research and development expense
   $ 3,743    $ 3,603    $ 140    $ 11,262    $ 10,594    $ 668

~~Research and development spending in TFE during the three and nine months ended October 2, 2021~~2022 decreased compared to the same periods in the prior year primarily due to ~~lower spending on DCP, semiconductor~~

~~Fan-out~~

~~and PV development,~~savings from cost reduction activities completed in the first quarter of fiscal 2022, offset in part by higher spending on ~~semiconductor HDD~~DCP development. ~~TFE~~R&D spending ~~consisted primarily of DCP, semiconductor~~

~~Fan-out,~~

~~HDD and PV development. Research and development spending increased in Photonics~~ during the ~~three and nine~~six months ended ~~October~~July 2, ~~2021, as~~2022 increased compared to the ~~same periods~~six months ended July 3, 2021 primarily due to $1.5 million in ~~the prior year, primarily~~expenditures related to ~~incremental~~

~~start-up~~

~~non-recurring~~

~~engineering costs associated with our IVAS product and higher~~the disposal of certain lab equipment as part of the realignment effort, offset by lower spending on the development of the next generation of our low light level CMOS camera. Research and development expenses do not include costs of $2.1 million and $7.5 million for the three and nine months ended October 2, 2021, respectively, or $3.9 million and $10.4 million for the three and nine months ended September 26, 2020, respectively, which are related to customer-funded Photonics contract R&D ~~programs and therefore included in cost of net revenues.~~

programs.

~~Table of Contents~~

Selling, general and administrative expense

Three months ended

Nine months ended



October 2,

2021

September 26,

2020

Change over

prior period

October 2,

2021

September 26,

2020

Change over

prior period



(In thousands)

Selling, general and administrative expense
   $ 5,752    $ 5,845    $ (93 ) $ 17,208    $ 17,426    $ (218 )


	Three months ended							Six months ended
	July 2, 2022		July 3, 2021		Change over prior period			July 2, 2022		July 3, 2021		Change over prior period

	(In thousands)
Selling, general and administrative expense	$	4,016	$	4,197	$	(181	)	$	8,265	$	8,531	$	(266	)

Selling, general and administrative expense consists primarily of selling, marketing, customer support, financial and management costs. Selling, general and administrative ~~expenses~~expense for the three months ended ~~October~~July 2, ~~2021~~2022 decreased compared to the ~~same period~~three months ended July 3, 2021 due to cost savings as a result of the realignment program implemented in the ~~prior year as~~first quarter of fiscal 2022, reimbursement under the TSA, and lower variable compensation expenses, ~~and lower~~

~~e-commerce~~

~~costs were~~ offset in part by higher stock compensation ~~expenses, higher legal expenses, and higher consulting expenses related to network security.~~expenses. Selling, general and administrative ~~expenses~~expense for the ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 decreased compared to the ~~same period in the prior year~~six months ended July 3, 2021 as lower variable compensation expenses, ~~and~~ lower

~~e-commerce~~

~~costs were offset in part by higher~~ stock compensation expenses, and TSA reimbursements were offset

in-part

one-time

severance charges associated with the realignment effort and higher legal and consulting fees. Selling, general and administrative expense for the three and six months ended July 2, 2022, is net of $394,000 and $1.2 million, respectively in TSA fees earned since the Photonics divestiture. The agreed-upon charges for such services are generally intended to allow the service provider to recover all costs and expenses ~~higher consulting expenses related to network security and higher bid and proposal costs for contract R&D work in Photonics.~~of providing such services.

Table of Contents

Cost reduction plans

re-alignment

effort, the Company will no longer be pursuing several DCP projects including the coating of the backside covers of smartphones, solar ion implantation (also known as ENERGi

), and advanced packaging for semiconductor manufacturing. We incurred restructuring costs of $1.2 million for estimated severance and the related modification of certain stock-based awards. Other costs incurred as part of the 2022 cost reduction plan include: (i) a benefit of $1.3 million related to the stock-based compensation forfeitures related to the employees affected by the reduction in workforce, (ii) $1.5 million for fixed asset disposals and (iii) $755,000 for write-offs of excess inventory. The 2022 Cost Reduction Plan reduced the workforce by 6 percent. The cost of implementing the 2022 Cost Reduction Plan was reported under cost of net revenues and operating expenses in the condensed consolidated statements of operations. Implementation of the 2022 Cost Reduction Plan is expected to reduce salary, wages and other employee-related expenses by approximately $2.1 million on an annual basis and reduce depreciation expense by $720,000 on an annual basis.

During the third quarter of fiscal 2021, Intevac substantially completed implementation of the 2021 cost reduction plan (the “2021 Cost Reduction Plan”), which was intended to reduce expenses and reduce its workforce by 5.2 percent. During the first half of 2021, the Company reported costs of $43,000 under the 2021 Cost Reduction Plan of which $9,000 was reported under cost of net revenues and $34,000 was reported under operating expenses. The total cost of implementing the 2021 Cost Reduction Plan was $319,000, of which $224,000 was reported under cost of net revenues and $95,000 was reported under operating ~~expenses.~~expenses during fiscal 2021. Substantially all cash outlays in connection with the 2021 Cost Reduction Plan were completed in the third quarter of fiscal 2021. Implementation of the 2021 Cost Reduction Plan is expected to reduce salary, wages and other employee-related expenses by approximately $2.0 million on an annual basis.

During the third quarter of fiscal 2020, Intevac substantially completed implementation of the 2020 cost reduction plan (the “2020 Cost Reduction Plan”), which was intended to reduce expenses and reduce its workforce by 1.0 percent. The total cost of implementing the 2020 Cost Reduction Plan was $103,000 of which $16,000 was reported under cost of net revenues and $87,000 was reported under operating expenses. Substantially all cash outlays in connection with the 2020 Cost Reduction Plan were completed in the third quarter of fiscal 2020. Implementation of the 2020 Cost Reduction Plan is expected to reduce salary, wages and other employee-related expenses by approximately $864,000 on an annual basis.

Interest income and other income (expense), net

Three months ended

Nine months ended



October 2,

2021

September 26,

2020

Change over

prior period

October 2,

2021

September 26,

2020

Change over

prior period



(In thousands)

Interest income and other income (expense), net
   $ 25    $ 8    $ 17    $ 75    $ 212    $ (137 )


	Three months ended						Six months ended
	July 2, 2022		July 3, 2021		Change over prior period		July 2, 2022		July 3, 2021		Change over prior period

	(In thousands)
Interest income and other, income (expense), net	$	317	$	20	$	297	$	310	$	50	$	260

~~Interest income and other income (expense), net is comprised of interest income, foreign currency gains and losses, and other income and expense such as gains and losses on sales of fixed assets.~~

Interest income and other income (expense), net in the three months ended ~~October~~July 2, ~~2021~~2022 included ~~$4,000~~$166,000 of interest income on investments, various other income of ~~$4,000,~~$11,000 and ~~$18,000~~$140,000 of foreign currency gains. Interest income and other income (expense), net in the ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 included ~~$31,000~~$175,000 of interest income on investments, various other income of $28,000 and ~~$16,000~~$107,000 of foreign currency gains. Interest income and other income (expense), net in the three months ended ~~September 26, 2020~~July 3, 2021 included ~~$46,000~~$10,000 of interest income on investments, various other income of $5,000 and $5,000 of foreign currency gains. Interest income and other income (expense), net in the six months ended July 3, 2021 included $27,000 of interest income on investments and various other income of ~~$3,000,~~$25,000, offset in part by $41,000 of foreign currency losses. Interest income and other income (expense), net in the nine months ended September 26, 2020 included $247,000 of interest income on investments and various other income of $12,000, offset in part by $47,000$2,000 of foreign currency losses. The ~~decrease~~increase in interest income in the three and ~~nine~~six months ended ~~October~~July 2, ~~2021 resulted from lower interest rates and lower invested balances~~2022 compared to the same periods in ~~2020.~~the prior year resulted from higher invested balances and higher interest rates.

~~Table of Contents~~

Provision for (benefit from) income taxes

Three months ended

Nine months ended



October 2,

2021

September 26,

2020

Change over

prior period

October 2,

2021

September 26,

2020

Change over

prior period



(In thousands)

Provision for income taxes
   $ 290    $ 217    $ 73    $ 157    $ 1,125    $ (968 )


	Three months ended							Six months ended
	July 2, 2022		July 3, 2021			Change over prior period		July 2, 2022		July 3, 2021			Change over prior period

	(In thousands)
Provision for (benefit from) income taxes	$	500	$	(165	)	$	665	$	526	$	(132	)	$	658

Intevac recorded income tax provisions of ~~$290,000~~$500,000 and ~~$157,000~~$526,000 for the three and ~~nine~~six months ended ~~October~~July 2, ~~2021,~~2022, respectively, and income tax ~~provisions $217,000~~benefits of $165,000 and ~~$1.1 million~~$132,000 for the three and ~~nine~~six months ended ~~September 26, 2020,~~July 3, 2021, respectively. The income tax provisions (benefits) for these three and ~~nine~~six month periods are based upon estimates of annual income (loss), annual permanent differences and statutory tax rates in the various jurisdictions in which Intevac operates. For the three ~~months~~and six month periods ended ~~October~~July 2, ~~2021,~~2022, Intevac recorded an income tax ~~provision~~provisions on ~~earnings~~profits of its international subsidiaries of ~~$179,000. For the nine months ended October 2, 2021, Intevac~~$390,000 and $364,000, respectively, and recorded ~~an income tax benefit of $29,000 on losses of its international subsidiaries. For the three~~$107,000 and ~~nine months ended October 2, 2021, Intevac recorded $111,000 and $183,000,~~$158,000, respectively, for withholding taxes on royalties paid ~~into~~to the United States from Intevac’s Singapore subsidiary as discrete items. For the three and ~~nine~~six month periods ended ~~September 26, 2020,~~July 3, 2021, Intevac recorded income tax ~~provisions~~benefits on ~~earnings~~losses of its international subsidiaries

Table of ~~$111,000~~Contents

of $189,000 and ~~$659,000,~~$208,000, respectively, and recorded ~~$98,000~~$24,000 and ~~$471,000,~~$72,000, respectively, for withholding taxes on royalties paid ~~into~~to the United States from Intevac’s Singapore subsidiary as discrete items. For all periods presented, Intevac utilized net operating loss carry-forwards to offset the impact of ~~the~~ global intangible

low-taxed

~~income (“GILTI”).~~income. Intevac’s tax rate differs from the applicable statutory rates due primarily to the establishment of a valuation allowance, the utilization of deferred and current credits and the effect of permanent differences and adjustments of prior permanent differences. Intevac’s future effective income tax rate depends on various factors, including the level of Intevac’s projected earnings, the geographic composition of worldwide earnings, tax regulations governing each region, net operating loss carry-forwards, availability of tax credits and the effectiveness of Intevac’s tax planning strategies. Management carefully monitors these factors and timely adjusts the effective income tax rate.

The income tax expense (benefit) consists primarily of income taxes in foreign jurisdictions in which we conduct business and foreign withholding taxes. We maintain a full valuation allowance for domestic deferred tax assets, including net operating loss ~~carryforwards~~carry-forwards and certain domestic tax credits. Intevac’s effective tax rate differs from the U.S. statutory rate in both ~~fiscal~~2022 and 2021 ~~and fiscal 2020~~ primarily due to the Company not recognizing an income tax benefit on the domestic loss.

Loss from discontinued operations, net of taxes


	Three months ended						Six months ended
	July 2, 2022		July 3, 2021		Change over prior period		July 2, 2022		July 3, 2021		Change over prior period

	(In thousands)
Loss from discontinued operations, net of taxes	$	238	$	2	$	236	$	373	$	938	$	(565	)

The loss from discontinued operations consists primarily of the results of operations of the Photonics business which was sold to EOTECH on December 30, 2021. Loss from discontinued operations for the three months ended July 2, 2022 includes contract termination costs associated with certain software maintenance contracts, settlement of the closing net working capital adjustment from the sale of the Photonics business to EOTECH and stock based compensation associated with 16 mutual employees of both the Company and the Buyer that are assisting in the assignment and novation of all government contracts and to sponsor the Buyer’s facility clearance from the Defense Counterintelligence and Security Agency of the U.S. government. Loss from discontinued operations for the six months ended July 2, 2022 includes salaries and wages and employee benefits up to and including January, 4, 2022, the date when employees were conveyed to the Buyer, severance for several employees that were not hired by the Buyer, stock-based compensation expense associated with the acceleration of stock awards, contract termination costs associated with software maintenance agreements, settlement of the net working capital adjustment and incremental legal expenses associated with the divestiture, offset in part by a stock based compensation divestiture-related forfeiture benefit. Loss from discontinued operations for the three and six months ended July 3, 2021 represents the loss from the Photonics division, net of tax.

Liquidity and Capital Resources

At ~~October~~July 2, ~~2021,~~2022, Intevac had ~~$51.4~~$110.2 million in cash, cash equivalents, restricted cash and investments compared to ~~$50.4~~$121.2 million at January ~~2, 2021.~~1, 2022. During the first ~~nine~~six months of fiscal ~~2021,~~2022, cash, cash equivalents, restricted cash and investments ~~increased~~decreased by ~~$1.1~~$11.0 million due primarily to cash used in operating activities, purchases of fixed assets and tax payments on net share settlements, partially offset by cash received from the sale of Intevac common stock to Intevac’s employees through Intevac’s employee benefit ~~plans, offset in part by to cash used in operating activities, purchases of fixed assets and tax payments for net share settlement.~~plans.

Cash, cash equivalents, restricted cash and investments consist of the following:


	October 2, 2021		January 2, 2021		July 2, 2022		January 1, 2022

	(In thousands)				(In thousands)
Cash and cash equivalents	$	33,696	$	29,341	$	53,669	$	102,728
Restricted cash		786		787		786		786
Short-term investments		11,137		14,839		31,168		10,221
Long-term investments		5,825		5,388		24,565		7,427

Total cash, cash equivalents, restricted cash and investments	$	51,444	$	50,355	$	110,188	$	121,162

Operating activities used cash of ~~$40,000~~$11.4 million during the first ~~nine~~six months of fiscal ~~2021~~2022 and generated cash of ~~$7.8~~$3.4 million during the first ~~nine~~six months of fiscal ~~2020.~~

~~Accounts receivable totaled $13.5 million at October 2, 2021 compared to $28.6 million at January 2,~~ 2021. Net inventories totaled $22.5 million at October 2, 2021 compared to $21.7 million at January 2, 2021. Net inventories at October 2, 2021 included one VERTEX SPECTRA system for DCP held at a customer’s factory previously under an evaluation agreement that expired. Net inventories at January 2, 2021 included one VERTEX SPECTRA system for DCP under evaluation in a customer’s factory and one MATRIX PVD system for advanced semiconductor packaging under evaluation in a customer’s factory. Accounts payable increased to $4.7 million at October 2, 2021 from $4.3 million at January 2, 2021 due to the timing of payments. Accrued payroll and related liabilities decreased to $5.7 million at October 2, 2021 compared to $7.7 million at January 2, 2021 due primarily to the settlement of 2020 bonuses. Other accrued liabilities decreased to $2.6 million at October 2, 2021 compared to $3.6 million at January 2, 2021 primarily due to lower deferred revenue balances and sales tax liabilities due to lower business levels.

Table of Contents

Accounts receivable totaled $30.3 million at July 2, 2022 compared to $14.3 million at January 1, 2022. Customer advances for products that had not been shipped to customers and included in accounts receivable were $19.3 million at July 2, 2022 which were collected on July 7, 2022. Net inventories totaled $11.8 million at July 2, 2022 compared to $5.8 million at January 1, 2022 due to increased manufacturing activities. Accounts payable decreased to $3.6 million at July 2, 2022 from $5.3 million at January 1, 2022. Accounts payable at January 1, 2022 included a payable of $2.0 million as a commission to the investment banker for the Photonics sale. Accrued payroll and related liabilities decreased to $3.5 million at July 2, 2022 compared to $5.5 million at January 1, 2022 due primarily to the settlement of 2021 bonuses. Other accrued liabilities decreased to $3.0 million at July 2, 2022 compared to $3.7 million at January 1, 2022 primarily due to lower other tax liability balances. Customer advances increased from $2.1 million at January 1, 2022 to $24.8 million at July 2, 2022 primarily as a result of new orders.

Investing activities ~~generated~~used cash of ~~$2.4~~$39.3 million during the first ~~nine~~six months of fiscal ~~2021. Proceeds~~2022. Purchases of investments net of proceeds from sales ~~net of purchases of investments~~ totaled ~~$3.1~~$38.4 million. Capital expenditures for the ~~nine~~six months ended ~~October~~July 2, ~~2021~~2022 were ~~$773,000.~~$888,000.

Financing activities generated cash of ~~$2.1~~$1.9 million in the first ~~nine~~six months of fiscal ~~2021.~~2022. The sale of Intevac common stock to Intevac’s employees through Intevac’s employee benefit plans generated cash of ~~$2.6~~$2.2 million. Tax payments related to the net share settlement of restricted stock units were ~~$545,000.~~$295,000.

Intevac’s investment portfolio consists principally of investment grade money market mutual funds, U.S. Treasury and agency securities, ~~asset backed securities,~~ certificates of deposit, asset-backed securities, commercial paper, municipal bonds and corporate bonds. Intevac regularly monitors the credit risk in its investment portfolio and takes measures, which may include the sale of certain securities, to manage such risks in accordance with its investment policies.

As of ~~October~~July 2, ~~2021,~~2022, approximately ~~$25.3~~$27.7 million of cash and cash equivalents and ~~$2.4~~$2.9 million of investments were domiciled in foreign tax jurisdictions. Intevac expects a significant portion of these funds to remain offshore in the short term. If the Company chose to repatriate these funds to the United States, it would be required to accrue and pay additional taxes on any portion of the repatriation subject to foreign withholding taxes.

We believe that our existing cash, cash equivalents and investments and cash flows from operating activities will be adequate to meet our liquidity needs for the next twelve months and for the foreseeable future beyond the next twelve months. Our significant funding requirements include procurement of manufacturing inventories, operating expenses,

non-cancelable

operating lease obligations, capital expenditures, settlement of the PAGA litigation and variable compensation. We have flexibility over some of these uses of cash, including capital expenditures and discretionary operating expenses, to preserve our liquidity position. Capital expenditures for the remainder of fiscal ~~2021~~2022 are projected to be approximately ~~between $2.0 million to $3.0~~$3.7 million related to network infrastructure and security, and laboratory and test equipment to support our R&D programs.

Off-Balance

Sheet Arrangements

Off-balance

sheet firm commitments relating to outstanding letters of credit amounted to approximately $786,000 as of ~~October~~July 2, ~~2021.~~2022. These letters of credit and bank guarantees are collateralized by $786,000 of restricted cash. We do not maintain any other

off-balance

sheet arrangements, transactions, obligations, or other relationships that would be expected to have a material current or future effect on the consolidated financial statements.

~~Climate Change~~

~~We believe that neither climate change, nor governmental regulations related to climate change, have had any material effect on our business, financial condition or results of operations.~~

Critical Accounting Policies and Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported. Intevac’s significant accounting policies are described in Note 1 to the consolidated financial statements included in Item 8 of Intevac’s Annual Report on Form

10-K

for the year ended January ~~2, 2021,~~1, 2022, filed with the SEC on February 17, ~~2021.~~2022. Certain of these significant accounting policies are considered to be critical accounting policies, as defined below.

A critical accounting policy is defined as one that is both material to the presentation of Intevac’s financial statements and requires management to make difficult, subjective or complex judgments that could have a material effect on Intevac’s financial conditions and results of operations. Specifically, critical accounting estimates have the following attributes: 1) Intevac is required to make assumptions about matters that are highly uncertain at the time of the estimate; and 2) different estimates Intevac could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on Intevac’s financial condition or results of operations.

Table of Contents

Estimates and assumptions about future events and their effects cannot be determined with certainty. Intevac bases its estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as Intevac’s operating environment changes. These changes have historically been minor and have been included in the consolidated financial statements as soon as they become known. In addition, management is periodically faced with uncertainties, the outcomes of which are not within its control and will not be known for prolonged periods of time. Many of these uncertainties are discussed in the section below entitled “Risk Factors.” Based on a critical assessment of Intevac’s accounting policies and the underlying judgments and uncertainties affecting the application of those policies, management believes that Intevac’s consolidated financial statements are fairly stated in accordance with US GAAP, and provide a meaningful presentation of Intevac’s financial condition and results of operations.

~~Table of Contents~~

For a description of critical accounting policies that affect our more significant judgments and estimates used in the preparation of our condensed consolidated financial statements, refer to our Annual Report on Form

~~10-K~~

~~for the year ended January 2, 2021 filed with the SEC on February 17, 2021.~~ There have been no material changes to our critical accounting policies during the ~~nine~~six months ended ~~October~~July 2, ~~2021.~~2022.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Not applicable to smaller reporting companies.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Intevac maintains a set of disclosure controls and procedures that are designed to ensure that information relating to Intevac required to be disclosed in periodic filings under the Securities Exchange Act of 1934, or Exchange Act, is recorded, processed, summarized and reported in a timely manner under the Exchange Act. In connection with the filing of this Quarterly Report on Form

10-Q

for the quarter ended ~~October~~July 2, ~~2021,~~2022, as required under Rule

13a-15(e)

of the Exchange Act, an evaluation was carried out under the supervision and with the participation of management, including the Chief Executive Officer (the “CEO”) and Chief Financial Officer (the “CFO”), of the effectiveness of Intevac’s disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on this evaluation, Intevac’s CEO and CFO concluded that our disclosure controls and procedures were effective as of ~~October~~July 2, ~~2021.~~2022.

Attached as exhibits to this Quarterly Report on Form

10-Q

are certifications of the CEO and the CFO, which are required in accordance with Rule

13a-14

of the Exchange Act. This Controls and Procedures section includes the information concerning the controls evaluation referred to in the certifications, and it should be read in conjunction with the certifications for a more complete understanding of the topics presented.

Definition of ~~Disclosure Controls~~disclosure controls

Disclosure controls are controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act, such as this Quarterly Report on Form

10-Q,

is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls are also designed to ensure that such information is accumulated and communicated to our management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Our disclosure controls include components of our internal control over financial reporting, which consists of control processes designed to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles in the U.S. To the extent that components of our internal control over financial reporting are included within our disclosure controls, they are included in the scope of our quarterly controls evaluation.

Limitations on the ~~Effectiveness~~effectiveness of ~~Controls~~controls

Intevac’s management, including the CEO and CFO, does not expect that Intevac’s disclosure controls or Intevac’s internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within Intevac have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Table of Contents

Changes in ~~Internal Control~~internal control over ~~Financial Reporting~~financial reporting

There were no changes in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form

10-Q

that have materially affected, or are reasonably likely to materially affect, Intevac’s internal control over financial reporting.

~~Table of Contents~~

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

From time to time, Intevac is involved in claims and legal proceedings that arise in the ordinary course of business. Intevac expects that the number and significance of these matters will increase as Intevac’s business expands. Any claims or proceedings against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time, result in the diversion of significant operational resources, or require us to enter into royalty or licensing agreements which, if required, may not be available on terms favorable to us or at all. Intevac is not presently a party to any lawsuit or proceeding that, in Intevac’s opinion, is likely to seriously harm Intevac’s business. For a description of our material pending legal proceedings, see Note 14 “Commitments and Contingencies” to the condensed consolidated financial statements in Part I, Item 1 of this Quarterly Report on Form

10-Q.

See also “Risk Factors” in Part II, Item 1A of this Quarterly Report on Form

10-Q.

Item 1A.

Risk Factors

The following factors could materially affect Intevac’s business, financial condition or results of operations and should be carefully considered in evaluating the Company and its business, in addition to other information presented elsewhere in this report.

Risks Related to Our Business

The industries we serve are cyclical, volatile and unpredictable.

A significant portion of our revenue is derived from the sale of equipment used to manufacture commodity technology products such as disk drives ~~PV solar cells~~ and cell phones. This subjects us to business cycles, the timing, length and volatility of which can be difficult to predict. When demand for commodity technology products exceeds production capacity, then demand for new capital equipment such as ours tends to be amplified. Conversely, when supply of commodity technology products exceeds demand, then demand for new capital equipment such as ours tends to be depressed. We cannot predict with any certainty when these cycles will begin or end. ~~Our~~For example, our sales of systems for magnetic disk production increased in 2016 as a customer began upgrading the technology level of its manufacturing capacity. Sales of systems and upgrades for magnetic disk production in 2017 and 2018 were higher than in 2016 as this customer’s technology upgrade continued. ~~Sales~~However, sales of systems and upgrades for magnetic disk production in 2019, 2020 and 2021 were ~~slightly~~ down from the levels in 2018 as this customer took delivery of ~~four systems. Sales~~fewer or no (in the case of ~~systems and upgrades for magnetic disk production in 2020 were down from the levels in 2019 as this customer took delivery of only two~~2021) systems. Intevac expects sales of systems and upgrades for magnetic disk production in ~~2021~~2022 will be at levels ~~lower than~~similar to the levels in ~~2020.~~2021.

Our equipment represents only a portion of the capital expenditure that our customers incur when they upgrade or add production capacity. Accordingly, our customers generally commit to making large capital expenditures far in excess of the cost of our systems alone when they decide to purchase our systems. The magnitude of these capital expenditures requires our customers to have access to large amounts of capital. Our customers generally reduce their level of capital investment during downturns in the overall economy or during a downturn in their industries.

~~In recent years~~ Reductions in capital investment could be particularly pronounced as the ~~photovoltaic (solar) market has undergone a downturn, which is likely to impact our sales~~cost of ~~PV equipment. The solar industry from time to time experiences~~obtaining capital increases during periods of structural imbalance between supply and demand, and such periods put intense pressure on our customers’ pricing. The solar industry is currently in such a period. Competition in solar markets globally and across the solar value chain is intense, and could remain that way for an extended period of time. During any such period, solar module manufacturers may reduce their sales prices in response to competition, even below their manufacturing costs, in order to generate sales and may do so for a sustained period of time. As a result, our customers may be unable to sell their solar modules or systems at attractive prices or for a profit during a period of excess supply of solar modules, which would adversely affect their results of operations and their ability to make capital investments such as purchasing our products.rapidly rising interest rates.

We must effectively manage our resources and production capacity to meet rapidly changing demand. Our business experiences rapid growth and contraction, which stresses our infrastructure, internal systems and managerial resources. During periods of increasing demand for our products, we must have sufficient manufacturing capacity and inventory to meet customer demand; attract, retain and motivate a sufficient number of qualified individuals; and effectively manage our supply chain. During periods of decreasing demand for our products, we must be able to align our cost structure with prevailing market conditions; motivate and retain key employees and effectively manage our supply chain.

Table of Contents

Supply chain and shipping disruptions could result in shipping delays, and increased product costs which may have a material adverse effect on our business, financial condition and results of operations.

Supply chain disruptions, resulting from factors such as the

COVID-19

pandemic, such as labor supply and shipping container shortages, have impacted, and may continue to impact, us and our suppliers. These disruptions have resulted in longer lead times and increased product costs and shipping expenses. While we have taken steps to minimize the impact of these increased costs by working closely with our suppliers and customers, there can be no assurances that unforeseen events impacting the supply chain will not have a material adverse effect on our business, financial condition and results of operations in the future. Additionally, the impacts supply chain disruptions have on our suppliers are not within our control. It is not currently possible to predict how long it will take for these supply chain disruptions to cease. Prolonged supply chain disruptions impacting us and our suppliers could interrupt product manufacturing, increase lead times, increase product costs and continue to increase shipping costs, all of which may have a material adverse effect on our business, financial condition and results of operations.

We are dependent on certain suppliers for parts used in our products.

We are a manufacturing business. Purchased parts constitute the largest component of our product cost. Our ability to manufacture depends on the timely delivery of parts, components and subassemblies from suppliers. We obtain some of the key components and subassemblies used in our products from a single supplier or a limited group of suppliers. If any of our suppliers fail to deliver quality parts on a timely basis, we may experience delays in manufacturing, which could result in delayed product deliveries, increased costs to expedite deliveries or develop alternative suppliers, or require redesign of our products to accommodate alternative suppliers. Some of our suppliers are thinly capitalized and may be vulnerable to failure, particularly during economic downturns and periods of rapidly rising interest rates and inflation.

Global economic conditions may harm our industry, business and results of operations.

We operate globally and as a result our business, revenues and profitability are impacted by global macroeconomic conditions. The success of our activities is affected by general economic and market conditions, including, among others, inflation rate fluctuations, interest rates, tax rates, economic uncertainty, political instability, changes in laws, and trade barriers and sanctions. Recently, inflation rates in the U.S. have increased to levels not seen in several years. Such economic volatility could adversely affect our business, financial condition, results of operations and cash flows, and future market disruptions could negatively impact us. Geopolitical destabilization could continue to impact global currency exchange rates, commodity prices, trade and movement of resources, which may adversely affect the ability of our customers and potential customers to incur the capital expenditures necessary to purchase our products and services.

The impact of the

COVID-19

~~outbreak,~~pandemic, or similar global health concerns, has negatively impacted and could continue to negatively impact our operations, supply chain and customer base.

The

COVID-19

~~outbreak~~pandemic has severely restricted the level of economic activity around the world, which may impact demand for our products. Our operations and supply chains for certain of our products or services have been and could continue to be negatively impacted by the regional or global outbreak of illnesses, including

COVID-19.

The impact of

COVID-19,

including changes in consumer behavior, pandemic fears, and market downturns as well as restrictions on business and individual activities has created significant volatility in the global economy and led to reduced economic activity. There have been extraordinary actions taken by federal, state, and local public health and governmental authorities to contain the spread of

COVID-19

and although many restrictions that were in place have eased in many localities, some areas that had previously eased restrictions have reverted to more stringent ~~limitations.~~ limitations in light of the emergence of new strains of

COVID-19.

There remains significant uncertainty concerning the magnitude of the impact and the duration of the

COVID-19

pandemic. The extent that our operations will continue to be impacted by the

COVID-19

Sales of our equipment are primarily dependent on our customers’ upgrade and capacity expansion plans and whether our customers select our equipment.

We have no control over our customers’ upgrade and capacity expansion plans, and we cannot be sure they will select, or continue to select, our equipment when they upgrade or expand their capacity. The sales cycle for our equipment systems can be a year or longer, involving individuals from many different areas of Intevac and numerous product presentations and demonstrations for our prospective customers. Our sales process also commonly includes production of samples and customization of our products. We do not typically enter into long-term contracts with our customers, and until an order is actually submitted by a customer there is no binding commitment to purchase our systems. In some cases, orders are also subject to customer acceptance or other criteria even in the case of a binding agreement.

Table of Contents

Sales of new manufacturing systems are also dependent on obsolescence and replacement of the installed base of our customers’ existing equipment with newer, more capable equipment. If upgrades are developed that extend the useful life of the installed base of systems, then we tend to sell more upgrade products and fewer new systems, which can significantly reduce total revenue.

Our 200 Lean HDD customers also experience competition from companies that produce alternative storage technologies like flash memory, which offer smaller size, lower power consumption and more rugged designs. These storage technologies are being used increasingly in enterprise applications and smaller form factors such as tablets, smart-phones, ultra-books, and notebook PCs instead of hard disk drives. Tablet computing devices and smart-phones have never contained, nor are they likely in the future to contain, a disk drive. Products using alternative technologies, such as flash memory, optical storage and other storage technologies are becoming increasingly common and could become a significant source of competition to particular applications of the products of our 200 Lean HDD customers, which could adversely affect our results of operations. If alternative technologies, such as flash memory, replace hard disk drives as a significant method of digital storage, then demand for our hard disk manufacturing products would decrease.

The Photonics business is also subject to long sales cycles because many of its products, such as our military imaging products, often must be designed into the customers’ end products, which are often complex

~~state-of-the-art~~

products. These development cycles are typically multi-year, and our sales are contingent on our customers successfully integrating our product into their product, completing development of their product and then obtaining production orders for their product from the U.S. government or its allies.

We operate in an intensely competitive marketplace, and our competitors have greater resources than we do.

In the market for our disk sputtering systems, we experience competition primarily from Canon Anelva, which has sold a substantial number of systems worldwide. In the PV equipment market, we face competition from large established competitors including Centrotherm Photovoltaics, Jusung, Kingstone, Von Ardenne and Belight Technology. In the military market for soldier and helicopter night vision goggles, Elbit Systems and L3Harris Technologies are large and well-established defense contractors and are the primary U.S. manufacturers of analog image intensifier tubes used in

~~Generation-III~~

~~night-vision devices. For long range airborne targeting applications, we compete against camera providers using low light CMOS imagery.~~ Some of our competitors have substantially greater financial, technical, marketing, manufacturing and other resources than we do, especially in the DCP ~~and PV~~ equipment ~~markets. With respect to U.S. military programs, we also face competition from other suppliers of components that receive development funding from the U.S. government.~~market. Our competitors may develop enhancements to, or future generations of, competitive products that offer superior price or performance features, and new competitors may enter our markets and develop such enhanced products. Moreover, competition for our customers is intense, and our competitors have historically offered substantial pricing concessions and incentives to attract our customers or retain their existing customers.

~~Table of Contents~~

We are exposed to risks associated with a highly concentrated customer base.

Historically, a significant portion of our revenue in any particular period has been attributable to sales of our disk sputtering systems to a limited number of customers. Our reliance on sales to relatively few customers has increased with the disposition of our Photonics business, and we expect that sales of our products to relatively few customers will continue to account for a high percentage of our revenues in the foreseeable future. This concentration of customers, when combined with changes in the customers’ specific capacity plans and market share shifts can lead to extreme variability in our revenue and financial results from period to period.

The concentration of our customer base may enable our customers to demand pricing and other terms unfavorable to Intevac and makes us more vulnerable to changes in demand by or issues with a given customer. Orders from a relatively limited number of manufacturers have accounted for, and will likely continue to account for, a substantial portion of our revenues. The loss of one of these large customers, or delays in purchasing by them, ~~could~~would have a material and adverse effect on our revenues.

Our operating results fluctuate significantly from quarter to quarter, which can lead to volatility in the price of our common stock.

Our quarterly revenues and common stock price have fluctuated significantly. We anticipate that our revenues, operating margins and common stock price will continue to fluctuate for a variety of reasons, including: (1) changes in the demand, due to seasonality, cyclicality and other factors in the markets for computer systems, storage subsystems and consumer electronics containing disks as well as cell phones ~~and PV solar cells~~ our customers produce with our systems; (2) delays or problems in the introduction and acceptance of our new products, or delivery of existing products; (3) timing of orders, acceptance of new systems by our customers or cancellation or delay of those orders; (4) new products, services or technological innovations by our competitors or us; (5) changes in our manufacturing costs and operating expense; (6) changes in general economic, political, stock market and industry conditions; and (7) any failure of our operating results to meet the expectations of investment research analysts or investors.

Any of these, or other factors, could lead to volatility and/or a rapid change in the trading price of our common shares. In the past, securities class action litigation has been instituted against companies following periods of volatility in the market price of their securities. Any such litigation, if instituted against Intevac, could result in substantial costs and diversion of management time and attention.

Our success depends on international sales and the management of global operations.

In previous years, the majority of our revenues have come from regions outside the United States. Most of our international sales are to customers in Asia, which includes products shipped to overseas operations of U.S. companies. We currently have manufacturing facilities in California and Singapore and international customer support offices in Singapore, China, and Malaysia. We expect that international sales will continue to account for a significant portion of our total revenue in future years. Certain of our suppliers are also located outside the United States.

Managing our global operations presents challenges including, but not limited to, those arising from: (1) global trade issues; (2) variations in protection of intellectual property and other legal rights in different countries; (3) concerns of U.S. governmental agencies

Table of Contents

regarding possible national commercial and/or security issues posed by growing manufacturing business in Asia; (4) fluctuation of interest rates, raw material costs, labor and operating costs, and exchange rates; (5) variations in the ability to develop relationships with suppliers and other local businesses; (6) changes in the laws and regulations of the United States, including export restrictions, and other countries, as well as their interpretation and application; (7) the need to provide technical and ~~spares~~spare parts support in different locations; (8) political and economic instability; (9) cultural differences; (10) varying government incentives to promote development; (11) shipping costs and delays; (12) adverse conditions in credit markets; (13) variations in tariffs, quotas, tax codes and other market barriers; and (14) barriers to movement of cash.

We must regularly assess the size, capability and location of our global infrastructure and make appropriate changes to address these issues.

Our success is dependent on recruiting and retaining a highly talented work force.

Our employees are vital to our success, and our key management, engineering and other employees are difficult to replace. We do not maintain key person life insurance on any of our employees. The expansion of high technology companies worldwide has increased demand and competition for qualified personnel and has made companies increasingly protective of prior employees. It may be difficult for us to locate employees who are not subject to

non-competition

agreements and other restrictions.

The majority of our U.S. operations are located in California where the cost of living and of recruiting employees is high. Our operating results depend, in large part, upon our ability to retain and attract qualified management, engineering, marketing, manufacturing, customer support, sales and administrative personnel. Furthermore, we compete with industries such as the hard disk drive, semiconductor, and solar industries for skilled employees. Failure to retain existing key personnel, or to attract, assimilate or retain additional highly qualified employees to meet our needs in the future, could have a material and adverse effect on our business, financial condition and results of operations.

~~Table of Contents~~

~~We are dependent on certain suppliers for parts used in our products.~~

Risks Related to Our Intellectual Property

Our growth depends on development of technically advanced new products and processes.

We have invested heavily, and continue to invest, in the development of new products, such as our 200 Lean HDD and ~~other PVD systems,~~ our coating systems for ~~DCP, our solar systems for PV applications, our digital night-vision products and our~~

~~near-eye~~

~~display products.~~DCP. Our success in developing and selling new products depends upon a variety of factors, including our ability to: predict future customer requirements; make technological advances; achieve a low total cost of ownership for our products; introduce new products on schedule; manufacture products cost-effectively including transitioning production to volume manufacturing; commercialize and attain customer acceptance of our products; and achieve acceptable and reliable performance of our new products in the field. Our new product decisions and development commitments must anticipate continuously evolving industry requirements significantly in advance of sales. In addition, we are attempting to expand into new or related markets, including the ~~PV and~~ display cover glass ~~markets.~~market. Our expansion into the ~~PV and~~ cover glass ~~markets~~market is dependent upon the success of our customers’ development plans. To date we have not recognized material revenue from such products. Failure to correctly assess the size of the ~~markets,~~market, to successfully develop cost effective products to address the ~~markets~~market or to establish effective sales and support of the new products would have a material adverse effect on future revenues and profits. In addition, if we invest in products for which the market does not develop as anticipated, we may incur significant charges related to such investments.

Rapid technological change in our served markets requires us to rapidly develop new technically advanced products. Our future success depends in part on our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. If new products have reliability or quality problems, our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance and payment for new products and additional service and warranty expenses.

Our business depends on the integrity of our intellectual property rights.

The success of our business depends upon the integrity of our intellectual property rights, and we cannot ensure that: (1) any of our pending or future patent applications will be allowed or that any of the allowed applications will be issued as patents or will issue with claims of the scope we sought; (2) any of our patents will not be invalidated, deemed unenforceable, circumvented or challenged; (3) the rights granted under our patents will provide competitive advantages to us; (4) other parties will not develop similar products, duplicate our products or design around our patents; or (5) our patent rights, intellectual property laws or our agreements will adequately protect our intellectual property or competitive position.

From time to time, we have received claims that we are infringing third parties’ intellectual property rights or seeking to invalidate our rights. We cannot ensure that third parties will not in the future claim that we have infringed current or future patents, trademarks or other proprietary rights relating to our products. Any claims, with or without merit, could be time-consuming, result in costly litigation, cause product shipment delays or require us to enter into royalty or licensing agreements. Such royalty or licensing agreements, if required, may not be available on terms acceptable to us.

Table of Contents

Risks Related to Government Regulation

We may not be able to obtain export licenses from the U.S. government permitting delivery of our products to international customers.

Many of our products, ~~especially Photonics products,~~ require export licenses from U.S. government agencies under the Export Administration ~~Act, the Trading with the Enemy Act of 1917, the Arms Export Act of 1976 or the International Traffic in Arms Regulations.~~Act. These regulations limit the potential market for some of our products. We can give no assurance that we will be successful in obtaining all the licenses necessary to export our products. Heightened government scrutiny of export licenses for defense related products has resulted in lengthened review periods for our license applications. ~~Exports to countries that are not considered by the U.S. government to be allies are likely to be prohibited, and even sales to U.S. allies may be limited.~~ Failure to comply with export control laws, including identification and reporting of all exports and

re-exports

of controlled technology or exports made without correct license approval or improper license use could result in severe penalties and revocation of licenses. Failure to obtain export licenses, delays in obtaining licenses, or revocation of previously issued licenses would prevent us from selling the affected products outside the United States and could negatively impact our results of operations.

~~Table of Contents~~

~~The Photonics business is dependent on U.S. government contracts, which are subject to fixed pricing, immediate termination and a number of procurement rules and regulations.~~

We sell our Photonics products and services directly to the U.S. government, as well as to prime contractors for various U.S. government programs. The U.S government is considering significant changes in the level of existing,

~~follow-on~~

~~or replacement programs. We cannot predict the impact of potential changes in priorities due to military transformations and/or the nature of future~~

~~war-related~~

activities. A shift of government priorities to programs in which we do not participate and/or reductions in funding for or the termination of programs in which we do participate, unless offset by other programs and opportunities, could have a material adverse effect on our financial position, results of operations, or cash flows.

Funding of multi-year government programs is subject to congressional appropriations, and there is no guarantee that the U.S. government will make further appropriations. Sales to the U.S. government and its prime contractors may also be affected by changes in procurement policies, budget considerations and political developments in the United States or abroad. For example, if the U.S. government is less focused on defense spending or there is a decrease in hostilities, demand for our products could decrease. The loss of funding for a government program would result in a loss of future revenues attributable to that program. The influence of any of these factors, which are beyond our control, could negatively impact our results of operations.

A significant portion of our U.S. government revenue is derived from fixed-price development and production contracts. Under fixed-price contracts, unexpected increases in the cost to develop or manufacture a product, whether due to inaccurate estimates in the bidding process, unanticipated increases in material costs, reduced production volumes, inefficiencies or other factors, are borne by us. We have experienced cost overruns in the past that have resulted in losses on certain contracts, and may experience additional cost overruns in the future. We are required to recognize the total estimated impact of cost overruns in the period in which they are first identified. Such cost overruns could have a material adverse effect on our results of operations.

Generally, government contracts contain provisions permitting termination, in whole or in part, without prior notice at the government’s convenience upon the payment of compensation only for work done and commitments made at the time of termination. We cannot ensure that one or more of the government contracts under which we, or our customers, operate will not be terminated under these circumstances. Also, we cannot ensure that we, or our customers, would be able to procure new government contracts to offset the revenues lost as a result of any termination of existing contracts, nor can we ensure that we, or our customers, will continue to remain in good standing as federal contractors.

~~As a U.S. government contractor we must comply with specific government rules and regulations and are subject to routine audits and investigations by U.S. government agencies.~~

We are subject to risks of

non-compliance

with environmental and other governmental regulations.

We are subject to a variety of governmental regulations relating to the use, storage, discharge, handling, emission, generation, manufacture, treatment and disposal of toxic or otherwise hazardous substances, chemicals, materials or waste. If we fail to comply with current or future regulations, such failure could result in suspension of our operations, alteration of our manufacturing process, remediation costs or substantial civil penalties or criminal fines against us or our officers, directors or employees. Additionally, these regulations could require us to acquire expensive remediation or abatement equipment and incur substantial expenses to comply with them.

In addition, climate change legislation is a significant topic of recent discussion and has generated and may continue to generate federal, international or other regulatory responses in the near future. If we or our suppliers, customers or partners fail to timely comply with applicable legislation, certain customers may refuse to purchase our products or we may face increased operating costs as a result of taxes, fines or penalties, or incur legal liability and reputational damage, which could harm our business, financial condition and results of operations.

~~Table of Contents~~

General Risk Factors

Our business could be negatively impacted by cyber and other security threats or disruptions.

~~As a defense contractor, we~~We face various cyber and other security threats, including ~~espionage and~~ attempts to gain unauthorized access to sensitive information and networks. Although we utilize various procedures and controls to monitor and mitigate the risk of these threats, there can be no assurance that these procedures and controls will be sufficient. These threats could lead to losses of sensitive information or capabilities; financial liabilities and damage to our reputation. If we are unable to maintain compliance with security standards applicable to defense contractors, we could lose business or suffer reputational harm. Cyber threats to businesses ~~in general~~ are evolving and include, but are not limited to, malicious software, destructive malware, attempts to gain unauthorized access to data, disruption or denial of service attacks, and other electronic security breaches that could lead to disruptions in our systems, unauthorized release of confidential, personal or otherwise protected information (ours or that of our employees, customers or partners), and corruption of data, networks or systems. We have experienced cybersecurity threats and incidents involving our systems and expect these incidents to continue. While none of the cybersecurity events have been material to date, a successful breach or attack could have a material adverse effect on our results of operations, financial condition or business, harm our reputation and relationships with our customers, business partners, employees or other third parties, and subject us to consequences such as litigation and direct costs associated with incident response. In addition, we could be impacted by cyber threats or other disruptions or vulnerabilities found in products we use or in our partners’ or customers’ systems that are used in connection with our business. These events, if not prevented or effectively mitigated, could damage our reputation, require remedial actions and lead to loss of business, regulatory actions, potential liability and other financial losses.

Changes to our effective tax rate affect our results of operations.

As a global company, we are subject to taxation in the United States, Singapore and various other countries. Significant judgment is required to determine and estimate worldwide tax liabilities. Our future effective tax rate could be affected by: (1) changes in tax laws; (2) the allocation of earnings to countries with differing tax rates; (3) changes in worldwide projected annual earnings in current and future years: (4) accounting pronouncements; or (5) changes in the valuation of our deferred tax assets and liabilities. Although we believe our tax estimates are reasonable, there can be no assurance that any final determination will not be different from the treatment reflected in our historical income tax provisions and accruals, which could result in additional payments by Intevac.

Difficulties in integrating past or future acquisitions or implementing strategic divestitures could adversely affect our business.

We have completed a number of acquisitions and dispositions during our operating history. We have spent and may continue to

Table of Contents

spend significant resources identifying and pursuing future acquisition opportunities. Acquisitions involve numerous risks including: (1) difficulties in integrating the operations, technologies and products of the acquired companies; (2) the diversion of our management’s attention from other business concerns; and (3) the potential loss of key employees of the acquired companies. Failure to achieve the anticipated benefits of the prior and any future acquisitions or to successfully integrate the operations of the companies we acquire could have a material and adverse effect on our business, financial condition and results of operations. Any future acquisitions could also result in potentially dilutive issuance of equity securities, acquisition or divestiture-related write-offs or the assumption of debt and contingent liabilities. In addition, we have made and will continue to consider making strategic ~~divestitures.~~divestitures, such as the disposition of our Photonics business. With any divestiture, there are risks that future operating results could be unfavorably impacted if targeted objectives, such as cost savings or earnout payments associated with the financial performance of the divested business, are not achieved or if other business disruptions occur as a result of the divestiture or activities related to the divestiture.

We could be involved in litigation.

From time to time, we may be involved in litigation of various types, including litigation alleging infringement of intellectual property rights and other claims and customer disputes. For example, we recently settled an action against us under the Private Attorneys General Act for $1.0 million, pending approval by the court. Litigation is expensive, subjects us to the risk of significant damages and requires significant management time and attention and could have a material and adverse effect on our business, financial condition and results of operations.

~~Table of Contents~~

Business interruptions could adversely affect our operations.

Our operations are vulnerable to interruption by fire, earthquake, floods or other natural disaster, quarantines or other disruptions associated with infectious diseases, national catastrophe, terrorist activities, war, disruptions in our computing and communications infrastructure due to power loss, telecommunications failure, human error, physical or electronic security breaches and computer viruses, and other events beyond our control. ~~Climate change has in the past increased, and is expected to continue to increase the incidence and severity of certain natural disasters.~~ We do not have a detailed disaster recovery plan. Despite our implementation of network security measures, our tools and servers may be vulnerable to computer viruses,

break-ins

and similar disruptions from unauthorized tampering with our computer systems and tools located at customer sites. Political instability could cause us to incur increased costs in transportation, make such transportation unreliable, increase our insurance costs or cause international currency markets to fluctuate. All these unforeseen disruptions and instabilities could have the same effects on our suppliers and their ability to timely deliver their products. In addition, we do not carry sufficient business interruption insurance to compensate us for all losses that may occur, and any losses or damages incurred by us could have a material adverse effect on our business and results of operations. For example, we self-insure earthquake risks because we believe this is the prudent financial decision based on the high cost of the limited coverage available in the earthquake insurance market. An earthquake could significantly disrupt our operations, most of which are conducted in California. It could also significantly delay our research and engineering effort on new products, most of which is also conducted in California. We take steps to minimize the damage that would be caused by business interruptions, but there is no certainty that our efforts will prove successful.

We could be negatively affected as a result of a proxy contest and the actions of activist stockholders.

A proxy contest with respect to election of our directors, or other activist stockholder activities, could adversely affect our business because: (1) responding to a proxy contest and other actions by activist stockholders can be costly and time-consuming, disruptive to our operations and divert the attention of management and our employees; (2) perceived uncertainties as to our future direction caused by activist activities may result in the loss of potential business opportunities, and may make it more difficult to attract and retain qualified personnel and business partners; and (3) if individuals are elected to our Board of Directors with a specific agenda, it may adversely affect our ability to effectively and timely implement our strategic plans.

We are required to evaluate our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act of 2002, and any adverse results from such evaluation could result in a loss of investor confidence in our financial reports and have an adverse effect on our stock price.

Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, our management must perform evaluations of our internal control over financial reporting. ~~Beginning in 2004, our Annual Report on Form~~

~~10-K~~

has included a report by management of their assessment of the adequacy of such internal control. We have completed the evaluation of our internal control over financial reporting as required by Section 404 of the Sarbanes-Oxley Act. Although our assessment, testing, and evaluation resulted in our conclusion that as of January ~~2, 2021,~~1, 2022, our internal control over financial reporting was effective, we cannot predict the outcome of our testing in future periods. Ongoing compliance with this requirement is complex, costly and time-consuming. If Intevac fails to maintain effective internal control over financial reporting; or our management does not timely assess the adequacy of such internal ~~control; or our independent registered public accounting firm does not deliver an unqualified opinion as to the effectiveness of our internal~~ control, ~~over financial reporting,~~ then we could be subject to restatement of previously reported financial results, regulatory sanctions and a decline in the public’s perception of Intevac, which could have a material and adverse effect on our business, financial condition and results of operations.

Table of Contents

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

On November 21, 2013, Intevac announced that its Board of Directors approved a stock repurchase program authorizing up to $30.0 million in repurchases. On August ~~15,~~20, 2018, ~~Intevac’s~~Intevac announced that its Board of Directors approved a $10.0 million increase to the original stock repurchase program for an aggregate authorized amount of $40.0 million. At ~~October~~July 2, ~~2021,~~2022, $10.4 million remains available for future stock repurchases under the repurchase program. Intevac did not make any common stock repurchases during the three months ended ~~October~~July 2, ~~2021.~~2022.

Item 3.

Defaults upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

Not applicable.

~~Table of Contents~~

Item 5.

Other Information

None.

Item 6.

Exhibits

The following exhibits are filed herewith:


Exhibit Number		Description

10.1		Form of PRSU Award Agreement (Company Stock Price Hurdle) under the 2022 Inducement Equity Incentive Plan*

10.2		Form of PRSU Award Agreement (Company Stock Price Hurdle) under the 2020 Equity Incentive Plan*

10.3		Consulting Agreement with Mark Popovich

31.1		Certification of President and Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of Executive Vice President, Finance and Administration, Chief Financial Officer, Treasurer and ~~Treasurer~~Secretary Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certifications Pursuant to U.S.C. 1350 Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.* **

~~101~~101.INS		~~The following financial statements from~~ XBRL Instance Document—the ~~Registrant’s Quarterly Report on Form~~ ~~10-Q~~ ~~for~~instance document does not appear in the ~~quarter ended October 2, 2021, formatted in~~Interactive Data File because its XBRL tags are embedded within the Inline XBRL (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations, (iii) Condensed Consolidated Statements of Comprehensive Income (Loss), (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.document

101.SCH		Inline XBRL Schema Document

101.CAL		Inline XBRL Calculation Linkbase Document

101.DEF		Inline XBRL Definition Linkbase Document

101.LAB		Inline XBRL Label Linkbase Document

101.PRE		Inline XBRL Presentation Linkbase Document

104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

*	Previously filed as an exhibit to the Company’s Report on Form 8-K filed May 19, 2022.

The certification attached as Exhibit 32.1 is deemed “furnished” and not deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 and is not to be incorporated by reference into any filing of Intevac, Inc. under the Securities Exchange Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof, irrespective of any general incorporation by reference language contained in any such filing, except to the extent that the registrant specifically incorporates it by reference.

3837

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

INTEVAC, INC.


	~~INTEVAC, INC.~~

Date: ~~November 2, 2021~~August 4, 2022

	By:	/s/ ~~WENDELL BLONIGAN~~NIGEL HUNTON
			~~Wendell Blonigan~~ Nigel Hunton
		President and Chief Executive Officer ~~and Director~~
		~~(Principal~~ (Principal Executive Officer)


Date: ~~November 2, 2021~~August 4, 2022

	By:	/s/ JAMES MONIZ
			James Moniz
		Executive Vice President, Finance and Administration,
		Chief Financial Officer, Secretary and Treasurer
		~~(Principal~~ (Principal Financial and Accounting Officer)

3938


	Nine Months Ended October 2, 2021										Nine Months Ended September 26, 2020

	(In thousands)
	HDD		DCP		PV		ASP		Total		HDD		PV		Total

Systems, upgrades and spare parts	$	14,034	$	3	$	219	$	3,850	$	18,106	$	29,189	$	400	$	29,589
Field service		4,425		14		60		0		4,499		4,334		2		4,336

Total TFE net revenues	$	18,459	$	17	$	279	$	3,850	$	22,605	$	33,523	$	402	$	33,925


	October 2,		January 2,
	2021		2021

	(In thousands)
Raw materials	$	11,262	$	9,999
Work-in-progress		6,929		4,832
Finished goods		4,262		6,858

	$	22,453	$	21,689


	Shares			Weighted-Average Exercise Price

Options outstanding at January 2, 2021		1,814,467		$	6.66
Options granted		0—		$	0—
Options cancelled and forfeited		(211,042	)	$	7.47
Options exercised		(73,744	)	$	5.89

Options outstanding at October 2, 2021		1,529,681		$	6.57

Options exercisable at October 2, 2021		1,317,356		$	6.78


	Three Months Ended				Nine Months Ended

	October 2, 2021		September 26, 2020		October 2, 2021		September 26, 2020

Stock Options:
Weighted-average fair value of grants per share	$	0	$	0	$	0	$	1.82
Expected volatility		0		0		0		46.04	%
Risk-free interest rate		0		0		0		0.44	%
Expected term of options (in years)		—		—		—		4.39
Dividend yield		0		0		0		NaN


	October 2, 2021

	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value

	(In thousands)
Cash and cash equivalents:
Cash	$	28,749	$	—	$	—	$	28,749
Money market funds		4,447		—		—		4,447
Municipal bonds		500		—		—		500

Total cash and cash equivalents	$	33,696	$	—	$	—	$	33,696
Short-term investments:
Certificates of deposit	$	6,299	$	3	$	—	$	6,302
Commercial paper		400		—		—		400
Corporate bonds and medium-term notes		2,919		1		—		2,920
Municipal bonds		515		—		—		515
U.S. treasury and agency securities		1,000		—		—		1,000

Total short-term investments	$	11,133	$	4	$	—	$	11,137
Long-term investments:
Asset backed securities	$	480	$	—	$	—	$	480
Certificates of deposit		500		—		1		499
Corporate bonds and medium-term notes		2,541		1		1		2,541
Municipal bonds		145		—		1		144
U.S. treasury and agency securities		2,161		—		—		2,161

Total long-term investments	$	5,827	$	1	$	3	$	5,825

Total cash, cash equivalents, and investments	$	50,656	$	5	$	3	$	50,658


	January 2, 2021

	Amortized Cost		Unrealized Holding Gains		Unrealized Holding Losses		Fair Value

	(In thousands)
Cash and cash equivalents:
Cash	$	24,729	$	—	$	—	$	24,729
Money market funds		3,612		—		—		3,612
Certificates of deposit		1,000		—		—		1,000

Total cash and cash equivalents	$	29,341	$	—	$	—	$	29,341
Short-term investments:
Certificates of deposit	$	6,450	$	2	$	0	$	6,452
Commercial paper		500		0		0		500
Corporate bonds and medium-term notes		2,929		6		0		2,935
Municipal bonds		400		—		—		400
U.S. treasury and agency securities		4,527		25		0		4,552

Total short-term investments	$	14,806	$	33	$	0	$	14,839
Long-term investments:
Certificates of deposit	$	500	$	0	$	0	$	500
Corporate bonds and medium-term notes		3,474		4		0		3,478
U.S. treasury and agency securities		1,409		1		0		1,410

Total long-term investments	$	5,383	$	5	$	0	$	5,388

Total cash, cash equivalents, and investments	$	49,530	$	38	$	0	$	49,568


	October 2, 2021
	Amortized Cost		Fair Value

	(In thousands)
Due in one year or less	$	16,080	$	16,084
Due after one through three years		5,827		5,825

	$	21,907	$	21,909


	Three Months Ended October 2, 2021			Nine Months Ended October 2, 2021			Three and Nine Months Ended September 26, 2020

	(In thousands)
	Severance and other employee-related costs

Beginning balance	$	—		$	—		$	—
Provision for restructuring reserves		276			319			103
Cash payments made		(276	)		(319	)		(103	)

Ending balance	$	—		$	—		$	—